Author: acn

HONG KONG, Aug 29, 2025 - (ACN Newswire via SeaPRwire.com) - Tianneng Power International Limited (the “Company”, together with its subsidiaries, collectively referred to as the “Group” or “Tianneng”), (Stock Code: 00819.HK) releases its interim report for the six-month period ended 30 June 2025.In the first half of 2025, adhering to the Group’s vision of Strategic Guidance and Reformation Breakthrough, Tianneng coordinated the three-wheeled strategy of Industry, Technology, and Capital. While solidifying the core competency of the lead-acid battery business, the Group also accelerated the expansion of overseas markets, released the Group’s built-up potential in new-energy battery, deepened the vertical construction of the battery recycle system, and drove the diversification of products and sustainability.Within the reporting period, the Group made a strategic pivot to reduce the trade business, achieved RMB 21.168 billion in revenue for the manufacturing business, which was stable compared to the same period in 2024, accounting for approximately 87.5% of the total revenue within the sector. In terms of the trade business, the Group realized an overall revenue of RMB 30.24 billion, which represented an 89.47% decrease from the same period of 2024. Within The manufacturing sector, the high-end eco-friendly battery business remained stable, providing a resilient financial support for the Group. The emerging businesses experienced significant growth, among which the Li-ion battery business achieved a revenue of RMB 0.501 billion, representing a 174.58% growth from the same period of 2024. Within the reporting period, the Group achieved a gross profit of RMB 2.537 billion, which is stable compared to the same period of 2024. In terms of operating cash flow, the Group achieved RMB 0.891 billion of net inflow, compared to a net outflow of RMB 0.162 billion in the same period of last year. Overall, in the first half of 2025, Tianneng demonstrated strong resilience, developmental momentum, and strategic commitment in a complex external environment.Internationalisation Accelerated, Overseas Expansion Bore FruitsInternational expansion is a vital fulcrum of the Group in strengthening global competitiveness and achieving incremental leaps. In the first half of 2025, the overseas business experienced remarkable growth with continuous positive feedback, achieving a revenue of RMB 0.226 billion, representing a 75.39% growth from the same period of 2024.Within the reporting period, guided by local demands, the Group accelerated its overseas expansion with global industrial resources, and set up operational teams in countries such as Thailand, Vietnam, and Turkey while developing a sales network in major areas including the Asia-Pacific, Europe, North America, the Middle-East and Africa. In addition, the Group’s production base in Vietnam is being constructed in an orderly manner while the capacity of the assembly base is robustly released, laying the groundwork for future developments in the region. The Group has developed customised products based on specific local demands and emphasised building localised operational teams, while advancing its “Overseas Service” strategy, and systematically constructed localised standards. With these developments, the Group was able to optimise its global supply chain and release future growth potentials.Core Business Stable and Resilient, with Promising Growth MomentumWithin the reporting period, the Group pursued a path of “Stability and Growth Duality” under a complex external environment and industrial structure re-balancing. The high-end eco-friendly battery business demonstrated resilience, achieving a revenue of RMB 18.292 billion, providing the vital financial stability for the Group. The high-end eco-friendly batteries are sealed, maintenance-less lead-acid batteries built with the Group’s innovation in design and manufacturing, highly adapting to the demands of the light electric vehicle market, with their cost and performance superiority, are also widely utilised in various fields, including backup power supplies, automobile batteries, and special-purpose industrial power batteries.The Group solidified its competencies in the core business, upgraded its intelligent manufacturing capabilities, improved the operational management system, consolidated its sales network, drove product quality and comprehensive market competitiveness growth, and fortified the resilience of lead-acid batteries in a complex market environment. Within the reporting period, the Group was able to effectively upgrade its manufacturing efficiency and supply-chain resilience through utilising intelligent manufacturing systems and equipment technology upgrades, while demonstrating effective results in cost management. Through the evolution of battery technologies and product upgrades, the Group constructed a differentiated product matrix targeting major fields of usage such as light electric vehicles, data centres, automobile start-stop batteries, and industrial power batteries,driving a service system upgrade with user value at its core, and organically merged the traditional sales network with an innovative digital ecosystem.Solidifying the Diversity of Technological Road-maps and Accelerating New Business Growth In the first half of 2025, the Group committed to the development of new-energy businesses, including Li-ion batteries, solid-state batteries, hydrogen fuel cells, and sodium-ion batteries, and systematically drove innovative breakthroughs, intelligent manufacturing upgrades, user-scenario extensions, and fostered new business growth. The Group’s Li-ion batteries business mainly targets power storage and low-speed power. Within the reporting period, the Group’s power storage and low-speed power business achieved major improvements both in terms of quality and quantity. Specific markets, such as industrial batteries and automobile A/C batteries, also saw improvements in market volume. Overall, the capacity utilisation of the Group’s new-energy business was significantly enhanced, with remarkable improvements in operational efficiency and revenue, RMB 0.501 billion, a 174.58% increase from the same period of 2024.The Group’s solid-state battery also achieved intermittent success within the three dimensions of high energy density, cycle longevity, and high-rate performance. The Group also formed strategic collaborations with industry leaders in the two-wheeled vehicle market and carried out solution testing with partners targeting the low-altitude flying vehicle market. The Group continued its investment in hydrogen fuel-cells with a full-chain R&D system and an expert team, with advanced products, began testing in user-scenarios such as two-wheeled vehicles, public transportation, heavy trucks, and special-purpose machinery, and collaborated with upstream and downstream partners in constructing an application ecosystem. The Group also spearheaded the development and application of sodium-ion battery technology, and conducted experiments for key metrics such as low-temperature and cycle longevity testing for scenarios such as power storage and automobile start-stop battery in a steady manner. Through the multi-roadmap approach, and the “technology breakthrough - user scenario verification - solution delivery” process, the Group’s new-energy business growth is gradually and steadily shifting from individual verification to chain-release, firmly supporting the business momentum.Strengthening the Recycling System and Fortifying Industrial CollaborationThe battery industry is at the core of the Group’s business, which systematically constructed a full-life industry chain of manufacturing, recycling, and reusing, forming a two-railed industry system of lead-acid battery and Li-ion battery, achieving efficient recycling. Within the reporting period, the recycling business of the Group achieved a revenue of RMB 1.8 billion, a 15.82% increase compared to the same period of 2024.As a leader in the recycling industry in China, the Group is continuously building an effective recycling network with front-end reach and back-end efficiency, promoting the efficiency of waste battery recycling empowered by the collaborative effort of businesses at scale, and achieving a top-of-industry recycling ratio of crucial materials. Within the reporting period, the Group continued to enhance the granularity and precision of the recycling process from recycling, processing, and reusing, improve the differentiating system for Li-ion battery recycling, and improve the resource synergies at core regions and user scenarios. Through uninterrupted exploration of technological potential and system performance optimisation, the Group was able to gradually achieve scale advantage and economic value of the recycling system, injecting continuous momentum for the industry.Looking forward, Tianneng will drive industrial upgrades through technological innovation, empower efficient operation through digitisation, rebuild the value-chain system through ecological collaboration, and seek growth through internationalisation. The Group will solidify its competencies in the lead-acid market, accelerate the research, application, and market expansion process of new energy batteries such as Li-ion battery and solid-state battery. The Group will strengthen its capabilities in battery recycling, enhance the collaborative efficiency of industry-chain integration while expediting its expansion into overseas markets and optimising localised operation, from product to service, and develop into a new-energy battery company that is competitive with a global vision. Finally, the Group will promote the convergence between its company values and social values with a growth mindset and build a new paradigm of sustainable and high-quality growth.About Tianneng Power International LimitedTianneng Power International Limited and its subsidiaries (collectively referred to as “Tianneng” or the “Company”), founded in 1986 and headquartered in China, has developed into a leading enterprise in the new energy battery and the light electric vehicle battery industry with a comprehensive manufacturing system and technological advantage. Tianneng was listed on the Main Board of The Stock Exchange of Hong Kong Limited (Stock Code: 00819. HK) in 2007. After nearly four decades of development, Tianneng has established lead-acid batteries as its core business, focusing on the market of motive batteries for light electric vehicles, while expanding its product in automotive start-stop systems, backup power for communication base stations and other diversified scenarios. The Company is also advancing the R&D, production and sales of lithium-ion batteries, hydrogen fuel cells, sodium-ion batteries and solid-state batteries, offering multi-technology battery solutions for special industrial vehicles, energy storage systems and other applications. Additionally, Tianneng strengthens its recycling economy initiatives around its core operations. Through a dual-track system for lead and lithium recycling, the Company achieves efficient resource regeneration and reuse, building a comprehensive ecosystem for the new energy industry. Copyright 2025 ACN Newswire via SeaPRwire.com.

Toronto, ON, August 28, 2025 - (ACN Newswire via SeaPRwire.com) - Digital Shovel, a leading innovator in crypto mining infrastructure solutions, is thrilled to announce the successful completion of its partnership with IREN (formerly Iris Energy Limited), marked by the delivery of the final batch totaling 493 MW of busway sets, including active units and spares. This milestone, achieved well ahead of schedule, underscores Digital Shovel’s commitment to excellence and reliability in supporting next-generation data center operations.The partnership, formalized in February 2024, saw Digital Shovel supply IREN with almost 500 MW of busways, critical to powering IREN’s expanding data centers, which are optimized for Bitcoin mining and AI cloud services using 100% renewable energy. The project was completed without delays, with deliveries consistently surpassing expectations, enabling IREN to advance its operational timeline.“We are incredibly proud of the seamless execution of this partnership with IREN,” said Scot Johnson, CEO of Digital Shovel. “Delivering all 493 MW of busway sets ahead of schedule is a testament to our team’s dedication and the strength of our innovative solutions. IREN’s vision for sustainable, high-performance data centers aligns perfectly with our mission, and we’re excited about the impact this project will have on their growth.”The early completion of this contract also positions both companies for future collaboration. “This project has been a fantastic opportunity to showcase what we can achieve together,” Johnson added. “We’re eager to explore new ventures with IREN as they continue to lead in renewable energy-powered data centers for Bitcoin mining and AI applications.”The success of this deployment lays the foundation for expanded collaboration as demand for infrastructure solutions continues to surge. With proven capacity to deliver at scale and speed, Digital Shovel is positioned to help power the next generation of energy-efficient data centers across North America.For more information about Digital Shovel and its solutions, please visit www.digitalshovel.com.About Digital ShovelDigital Shovel is a leading vertically integrated HPC, AI and Bitcoin Mining systems manufacturer, building critical elements for datacenter construction. This includes turnkey modular datacenters, as well as infrastructure including switchgear, Smart PDUs, busway systems and more. For more info, visit www.DigitalShovel.com About IRENIREN (NASDAQ: IREN), formerly Iris Energy Limited, is an Australia-based company operating next-generation data centers powered by 100% renewable energy. With facilities optimized for Bitcoin mining, AI cloud services, and other power-dense computing applications, IREN is a global leader in sustainable, high-performance data center solutions. For more information, visit www.iren.com.Media Contact:Press@DigitalShovel.comhttps://www.digitalshovel.com Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 29, 2025 - (ACN Newswire via SeaPRwire.com) - Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its interim results for the six months ended 30 June 2025 (the "Reporting Period"). The Group adopted “one horizontal, one vertical” as its core business strategy: horizontally, it extended a lean management system to advance multi-mode collaboration among medical institution alliances; vertically, it focused on specialty-specific innovation in medical diagnostics to fast-track the translation and implementation of new technologies and products. Meanwhile, the Group leveraged AI to enhance the comprehensive solutions for medical institution alliances, promoted the practical application of AI in healthcare scenarios, and continuously strengthened the value of empowering clinical practices, demonstrating strong operational resilience.In the first half of 2025, due to multiple factors, including the centralized drug-procurement program, cost controls of medical insurance, and fierce market competition, the Group’s short-term results did not meet expectations. However, the Group remained committed to product and business model innovation, and further refined the mechanisms and processes of its operational management. By adhering to lean operations, the overall performance has achieved significant improvements. During the Reporting Period, the Group’s gross profit margin reached approximately 34.0%, representing an improvement of approximately 4.4% over the overall gross profit margin for 2024. The net loss amounted to RMB55.4 million, a significant decrease of 56.1% compared to the same period last year. The joint construction business remained the Group’s largest business segment, which recorded the revenue of RMB180.3 million, accounting for 57.6% of the total revenue, increased by approximately 9.6% as compared with the same period last year, achieving significant outcomes in empowering medical alliance clients through in-depth services, paving the way for the Group’s long-term high-quality growth. During the Reporting Period, the Group’s diagnostic testing services recorded revenue of RMB313.2 millionSteadily implementing “one horizontal, one vertical” strategy, with notable achievements in hospital-enterprise partnerships“One horizontal” ——Extending lean management system to deepen diverse forms of collaboration within medical institution alliancesYunkang has been committed to developing an innovative service mode for the joint construction of medical institution alliances featuring “professionalism as the foundation, standardization as the core, digital intelligence as the means, synergization as the goal”. During the Reporting Period, the Group provided nearly 450 alliance clients with multi-scenario solutions tailored to different clinical needs, including AI+ digital intelligence solutions for medical institution alliances, comprehensive collaborations with medical laboratories, solutions for regional/pathology centers and precision medicine center, and specialty-based solutions for alliance development, among other multi-model collaboration services. By leveraging Yunkang’s strengths, the Group assisted healthcare institutions at all levels in enhancing service capabilities and expanding service coverage, established a hierarchical and coordinated healthcare service system, and promoted the development of regional hierarchical diagnosis and treatment services.During the Reporting Period, despite increasingly fierce market competition, the Group maintained solid growth in the joint construction business through continuous deep collaboration with leading hospitals and municipal and county-level hospitals, further consolidating its competitive advantage.“One vertical” ——Joint innovation platform for diagnostic testing serves as strong driver for R&DThe Group has always focused on “clinical needs”, continuously strengthening hospital-enterprise collaboration and pioneering the establishment of a joint innovation platform for diagnostic testing, driving business expansion and product competitiveness. During the Reporting Period, the Group forged joint diagnostic innovation partnerships with dozens of top-tier medical institutions nationwide, delivering a portfolio of testing products addressing multiple infectious syndromes, including respiratory tract infections, central nervous system infections, urinary tract infections, gynecological infections, and tuberculosis, as well as genetic testing products for personalized medication. Collectively, these innovative products have served nearly 300 clients across the country, and achieved sustained growth in testing revenue.During the Reporting Period, Yunkang and Guangdong Provincial People’s Hospital successively launched a series of new panel products covering respiratory tract infections, central nervous system infections, and invasive fungal infections, successfully creating a standardized incubation model for domestic hospital-enterprise research innovation and translation, as well as a “1+N” medical inspection collaboration network. Moreover, throughout the process of scientific and technological innovation, both parties have gained rich clinical experience. With the active involvement and sustained efforts of dozens of domestic diagnostic experts and scholars, they formulated the Expert Consensus on the Application of tNGS for Clinical Standardization, which was published during the Reporting Period in Chinese Journal of Laboratory Medicine, a leading journal in China’s diagnostic field. During the Reporting Period, Yunkang also maintained close collaboration with the First Affiliated Hospital of Guangzhou Medical University, one of China’s top-tier hospitals, and successfully developed a urinary tNGS product, advancing the clinical practice of precision diagnosis and treatment for urinary tract infections. Simultaneously, Yunkang partnered with the First Affiliated Hospital of Jinan University to establish a “university-hospital-enterprise joint innovation platform” and incubated and operated the “innovation project of psychiatric drug genetic testing”, which has successfully yielded genetic testing products for antidepressants, anti-anxiety drugs, and sedative-hypnotics.AI empowers multi-modal solutions for medical institution alliances, improving quality and efficiency to deepen client services During the Reporting Period, Yunkang fully employed DeepSeek and achieved digital deployment across its platforms. Centered on the core concepts of “AI+” and “precision diagnostics”, Yunkang extensively applied artificial intelligence technology across the multi-technology platforms of its medical laboratories. Taking the in-depth integration of AI technology with Yunkang pathology diagnosis platform as an example, the per-slide efficiency of AI-empowered diagnostic was continuously optimized, achieving simultaneous improvements in intelligence, efficiency, and quality. Moreover, through the deployment of intelligent applications, Yunkang realized smart online customer services and the efficient review of results and reports, which fully streamlined diagnostic service processes and improved experience and satisfaction of its client services. In the process of jointly developing new technologies and products through hospital-enterprise R&D, Yunkang’s AI technology empowered product innovation and R&D across multiple aspects, including bioinformatics analysis, report interpretation, disease risk assessment, and development and translation of novel products, by leveraging the powerful data analysis, modeling, and predictive capabilities of large-scale AI models. This has accelerated the clinical implementation.Notably, Yunkang unveiled its medical AI model “ZhiYun” developed in collaboration with Runda Medical and Huawei, spanning the entire clinical workflow from pre-diagnosis to diagnosis and post-diagnosis. It will provide more efficient and convenient support and experience across all stages of clinical medical services. Meanwhile, Yunkang signed a strategic cooperation agreement with Runda Medical to strengthen in-depth collaboration across the industrial ecosystems in “AI + IVD + healthcare services”, jointly promoting the development and application of large-scale AI models in the medical field, and providing clients with digital-intelligence healthcare solutions. In the future, “ZhiYun”, the medical AI model, will be piloted in Yunkang’s healthcare partners and gradually rolled out nationwide, to improve quality and efficiency of medical institution alliance operations.Future prospects2025 marks the final lap for implementing the 14th Five-Year Plan. China has accelerated the capacity expansion of premium healthcare resources and their extension to lower-tier markets, resulting in a more balanced regional distribution. The country has also expedited the development of medical institution alliances and driven their upgrade from “framework building” to “high-quality operation”. Clinical treatment is also shifting from “broad-spectrum therapies” to “precision medicine”, with the growth potential of the industry continuing to be realized. At the same time, AI technology has continued to empower hierarchical diagnosis and treatment services, and the industry is embracing new growth opportunities. Looking ahead, Yunkang will continue to keep pace with industry development trends and align with national policies, further strengthening the value of empowering clinical practices, and persistently exploring the “product innovation + business innovation” dual-pronged model to accelerate business development, deeply empower medical testing services, and benefit more residents.Yunkang Group Limited (Stock Code: 2325)Yunkang Group is a leading medical operation service provider in China, which started to provide standardized medical diagnostic services to medical institutions at all levels as early as 2008. Leveraging its own professional diagnostic capabilities and the nationwide service network of integrated healthcare systems, Yunkang has gradually grown to become a medical operation service platform. Meanwhile, Yunkang is a medical operation service provider in China offering a full suite of diagnostic testing services which are diagnostic outsourcing services and diagnostic testing services for medical institution alliances. Yunkang provides diagnostic services through on-site diagnostic centers to collaborative hospitals in the integrated healthcare systems in China and assists them in improving their clinical diagnosis capabilities through co-developing diagnostic centers. As of today, Yunkang has successfully provided professional services to nearly 450 on-site diagnostic centers. As of June 30, 2025, the hospitals we collaborated with were located across 31 provinces and municipalities in China. Copyright 2025 ACN Newswire via SeaPRwire.com.

West Palm Beach, FL, Aug 28, 2025 - (ACN Newswire via SeaPRwire.com) - U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), has agreed to a multi-year partnership as the new title sponsor of The Palm Beaches Marathon. The U.S. Polo Assn. Palm Beaches Marathon, a race owned and managed by Ken Kennerly's K2 Sports Ventures, will be held in Downtown West Palm Beach, Florida, on December 13-14, 2025.USPA MarathonThis renowned marathon event is recognized for its beautiful views of the waterfront and palm-tree-lined streets and welcomes runners from across the country and around the world to the warmth of Florida during the cold winter months. It is also a qualifier for the legendary Boston Marathon."U.S. Polo Assn. is honored to be the Title Sponsor of The Palm Beaches Marathon, an iconic event that, like our brand, is deeply rooted in this vibrant community of Palm Beach County," said J. Michael Prince, President and CEO of USPA Global, the company that oversees the global, multi-billion-dollar U.S. Polo Assn. brand. "While our sport-inspired brand has a worldwide footprint in more than 190 countries, our heart and heritage are right here in The Palm Beaches, home to USPA Global, the United States Polo Association, and the USPA National Polo Center, the most prestigious polo destination in the world."The race weekend will include the 5K and 10K at 7:30 a.m. Saturday, December 13, followed by the featured Marathon, Half Marathon, and Marathon Relay on Sunday, December 14 at 6 a.m. Early registration is now open. Cost is $130 for the Marathon and $100 for the Half Marathon. The early registration fee for the 10K is $60, and $45 for the 5K. To register for The U.S. Polo Assn. Palm Beaches Marathon, visit palmbeachmarathon.com.A Health and Fitness Expo will coincide with race packet pickup on Friday, December 12, from 12 p.m. to 6 p.m. and Saturday, December 13, from 10 a.m. to 6 p.m. at the Meyer Amphitheatre, 104 Datura St., West Palm Beach. The Expo will feature the latest in health and fitness products and services, running apparel, and upcoming race information."We are excited to add a renowned global brand like U.S. Polo Assn. as the Title Sponsor of The Palm Beaches Marathon," Kennerly said. "This is a massive deal for the future of our race and its appeal to runners throughout the world. The Palm Beaches are a globally recognized blue-chip destination, and we are looking forward to continuing to grow the race not only in our community, but also on an international level."U.S. Polo Assn. brand products include apparel for men, women, and children, as well as accessories, luggage, watches, shoes, home furnishings, and more, with distribution across 190 countries through independent retail stores, department stores, U.S. Polo Assn. brand stores and e-commerce."Partnering with The Palm Beaches Marathon allows us to celebrate athletic excellence, community spirit, health and wellness, as well as the shared passion for sport that connects us locally and around the world. From the polo fields to the streets of Palm Beach, we are inspired by the athletes who give their all, and we look forward to sharing in the energy, camaraderie, and world-class competition that make The Palm Beaches Marathon truly special," Prince added.The race will support local charities, soon to be announced.WPBF 25, the Hearst-owned ABC Affiliate, will return as the Official Broadcast Station of the race and will provide extensive pre- and post-race coverage on all on-air and digital channels, as well as produce a live broadcast on Marathon race morning."WPBF 25 is thrilled to extend our partnership for a second year in a row as the Official Broadcast Station of the U.S. Polo Assn. Palm Beaches Marathon, reaffirming our commitment to help bring such a unique and exciting event like this to our community," said President and General Manager, Caroline Taplett. "Working together with our incredible partners, Ken Kennerly and the Marathon team, we are dedicated to promoting a more connected community, supporting local businesses, and inspiring participants, locally, nationally, and internationally to join us in beautiful South Florida for this one-of-a-kind experience."About U.S. Polo Assn.U.S. Polo Assn. is the official sports brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890 and based at the USPA National Polo Center (NPC) in Wellington, Florida. This year, U.S. Polo Assn. celebrates 135 years of sports inspiration alongside the USPA. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,100 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. The brand sponsors major polo events around the world, including the U.S. Open Polo Championship®, held annually at NPC in The Palm Beaches, the premier polo tournament in the United States. Historic deals with ESPN in the United States, TNT and Eurosport in Europe, and Star Sports in India now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, PGA Tour, and Formula 1, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global growth. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world. For more information, visit uspoloassnglobal.com and follow @uspoloassn.About The U.S. Polo Assn. Palm Beaches MarathonThe U.S. Polo Assn. Palm Beaches Marathon is a premier winter running event held annually in West Palm Beach, which features a range of race distances designed for runners of all abilities, including a full marathon, half marathon, 10K, 5K, and a 4-person marathon relay. Highlighted by a 100% flat, USATF-certified course, the Marathon serves as a Boston Marathon qualifier. The scenic route allows runners to experience West Palm Beach's vibrant downtown as it winds along palm-lined Flagler Drive, past historic neighborhoods, and features sparkling waterfront views. The event also supports community and charity efforts. Visit palmbeachmarathon.com.Contact InformationStacey KovalskyU.S. Polo Assn.skovalsky@uspagl.com(954) 673-1331Gary FermanSpecialty Sports(954) 558-5203SOURCE: U.S. Polo Assn. Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 28, 2025 - (ACN Newswire via SeaPRwire.com) - Shoucheng Holdings Limited (0697.HK, hereinafter referred to as “Shoucheng Holdings”), Beijing Shoucheng Robotics Technology Industry Co., Ltd. (hereinafter referred to as “Shoucheng Robotics”), IAT Automobile Technology Co., Ltd. (300825.SZ, hereinafter referred to as “IAT”), and Beijing IATROBOT Technology Co., Ltd. (hereinafter referred to as “IATROBOT”) officially signed a strategic cooperation framework agreement.The four parties will leverage their respective strengths to carry out comprehensive cooperation in technological innovation, application deployment, industry chain collaboration, and talent cultivation within the robotics sector, jointly accelerating the development of new business models in the “Robotics + Automobiles” field.I. Industry Background: Robotics Entering the Acceleration Phase of Application DeploymentAt present, the global robotics industry is in a stage of rapid development, with national strategies and policies being introduced intensively. On August 26, the State Council officially released the Opinions of the State Council on Deeply Implementing the “AI+” Initiative (Guo Fa [2025] No. 11), which explicitly calls for promoting the extensive and in-depth integration of artificial intelligence with various industries and fields across the economy and society, and accelerating the formation of new models of intelligent economy and intelligent society characterized by human-machine collaboration, cross-industry integration, and co-creation.Under this national strategy, the robotics industry is shifting from “technological breakthroughs” to “application deployment.” Automobiles and robotics, as two highly complementary industries, are increasingly showing a trend of cross-sector integration. The cooperation between Shoucheng Holdings and IAT Group, under the dual drivers of favorable policy and strong market demand, will inject new momentum into robotics applications across key segments such as R&D, manufacturing, transportation, and mobility services.IAT is a leading enterprise in China’s automotive design field and the only independent automotive design company listed on the A-share market. The company provides full-process services ranging from complete vehicle R&D and design to core component manufacturing, while pursuing a globalization strategy of “technology + supply chain.” According to public information, IAT has served more than 80 clients and participated in the development of nearly 500 vehicle models. Its clients include major OEMs such as FAW, Dongfeng, BAIC, Geely, emerging EV brands, as well as joint-venture automakers. This highlights IAT’s strong OEM resources and delivery capabilities across the automotive value chain.At the same time, through its subsidiary — Beijing IATROBOT Technology Co., Ltd. — IAT has officially entered the robotics sector. IATROBOT is dedicated to building an integrated R&D, design, and simulation training platform, capable of supporting multi-scenario robotics development from simulation and testing to optimization. The company has already launched multiple R&D projects, including wheeled robots, underwater robots, drilling robots, and pet-care robots, demonstrating its potential in cross-scenario development and industry collaboration. The involvement of IATROBOT expands the scope of this cooperation beyond traditional automotive design, providing important support for the integration of robotics R&D, simulation, and automotive industrialization.By partnering with IAT and IATROBOT, Shoucheng will be able to embed robotics technologies deeply into the core stages of the automotive value chain, such as vehicle manufacturing, intelligent assembly, and production line testing. This will enable robots to truly enter the production line and accelerate industrial adoption. This strategic cooperation is not merely a technological connection — it leverages IAT’s extensive OEM client network to move robotics scenarios from “next-door demonstrations” directly into the “factory workshop,” bridging the crucial pathway between R&D validation and scaled industrial delivery.II. Key Areas of Cooperation: Balancing R&D Breakthroughs and Application DeploymentGuided by the State Council’s “AI+” Initiative, the four parties will anchor their collaboration on the full chain of “technology R&D — industrial application — ecosystem co-construction,” working together to drive industrial innovation. The cooperation will focus on the following areas to promote the deep integration of robotics and automobiles:(1) Technological Innovation and Joint R&DThe four parties will jointly build an integrated robotics R&D and simulation platform, drawing on the comprehensive R&D system of the automotive industry. The focus will be on achieving breakthroughs in key areas such as motion control, structural optimization, automotive-grade components, and large-scale manufacturing. Leveraging NVIDIA Isaac/Omniverse technology, the parties will co-develop an integrated simulation training platform that not only supports simulation of robotics applications in automotive R&D, manufacturing, and testing, but also enables cross-scenario simulations such as collaborative operations between autonomous driving vehicles and logistics robots.In addition, a mechanism for data and outcome sharing will be established: Shoucheng Holdings will provide operational data resources from transportation and mobility scenarios, while IAT will contribute expertise in automotive engineering and robotics R&D, together forming a complete closed loop spanning simulation — R&D — validation — production line application.(2) Priority Procurement and Synergy MechanismAcross R&D design, simulation training, complete machine and component supply, the four parties will adopt a priority procurement mechanism, under which signatories will be given preference as partners under equivalent conditions. Shoucheng Holdings and Shoucheng Robotics will focus on product promotion, distribution, and supporting services, while IAT and IATROBOT will concentrate on technology R&D, engineering validation, and customized whole-machine development.The parties will also work together to advance secondary development of robotic systems, ensuring optimal adaptation of robotics products to scenarios such as automotive production lines, intelligent assembly, and line testing. Through division of labor and collaborative mechanisms, a complementary cycle of product supply — technological innovation — application feedback will be established, accelerating the conversion of results and enhancing commercialization efficiency.(3) Talent DevelopmentLeveraging the research and industrial platforms of Shoucheng, IAT, and their partners, the four parties will jointly carry out technological problem-solving, simulation training, and application pilots, providing researchers and engineers with cross-industry, cross-scenario practical environments. Regular technical seminars and industry forums will be held, inviting experts and upstream and downstream enterprises to participate, thereby establishing a joint talent development mechanism. This initiative aims to cultivate a new generation of young researchers with both automotive engineering backgrounds and practical experience in robotics industrialization, laying a solid talent foundation for long-term growth.(4) Expanding Development HorizonsThe four parties will closely align with national strategies for “AI+” and robotics industry development, with a focus on scaling up “Robotics + Automobiles” applications in R&D, manufacturing, testing, and mobility services. Building on this foundation, the cooperation will gradually extend into broader fields such as smart transportation, intelligent manufacturing, healthcare, education, and public services, covering the design, R&D, production, testing, and commercialization of robots and core components. At the same time, by integrating capital and industry, the parties will drive coordinated upgrades across the value chain, ultimately forming a full-cycle closed loop from R&D validation to large-scale application. This will create a demonstrative “Robotics + Automobiles” application matrix, achieving mutual benefits and long-term value creation.III. Strategic Significance: Establishing a New Benchmark for Robotics ApplicationsThe greatest value of the robotics industry lies in real-world applications, and “Robotics + Automobiles” stands out as one of the most promising and high-potential application directions. From complete vehicle R&D to intelligent manufacturing, from traffic scheduling to smart mobility, robots will create tremendous value across the entire automotive value chain.Shoucheng Holdings, leveraging its capital platform, ecosystem resources, and industrial fund advantages, has invested in leading domestic enterprises such as Unitree Robotics, Galbot, Noetix Robotics, Galaxea-AI, and Booster Robotics, equipping it with the capability to integrate frontier technologies. Shoucheng Robotics has established collaborations with hundreds of high-quality upstream and downstream enterprises, making it one of the most comprehensive resource-linking platforms in China. IAT and IATROBOT, in turn, bring mature automotive engineering systems into robotics R&D and industrialization. Together, the combined strengths of both sides will form a complete pathway of “R&D — iteration — application — scale-up.”By joining forces with IAT, Shoucheng will further integrate its scenario resources and industrial ecosystem with IAT’s expertise in vehicle R&D, engineering capabilities, and industrialization experience. Over the next one to two years, the cooperation will focus on the deep integration of “Robotics + Automobiles,” taking the lead in demonstrating large-scale applications across vehicle R&D, production and manufacturing, smart transportation, and mobility services. This will accelerate the transition of robotics from laboratories to industrialization and large-scale deployment, creating a demonstrative “Robotics + Automobiles” application matrix. At the same time, the cooperation will also look to the international market, bringing Chinese solutions to the global stage, fostering new quality productivity, and generating long-term value for shareholders.Posted by All Way Success Company Limited for Shoucheng Holdings www.shouchengholdings.com [HKSE:0697, FRA:SHVA, OTCPK:SHNHF] Copyright 2025 ACN Newswire via SeaPRwire.com.

Financial Highlights (Unaudited)(HKD Thousand)Six months ended 30 June20252024Revenue122,775135,347Gross Profit47,27748,767Profit Attributable to Owners of the Company8,17218,510Gross Profit Margin39%36%Basic Earnings per Share (HK cents)0.581.31HONG KONG, Aug 28, 2025 - (ACN Newswire via SeaPRwire.com) Dynasty Fine Wines Group Limited (“Dynasty” or the “Group”) (Stock Code: 00828), a premier grape winemaker in China, today announced its unaudited interim results for the six months ended 30 June 2025.In the first half of 2025, as the Group strengthened the effort for dry white market in coastal region and the new launch of white wine and sparkling wine products, the Group’s sales revenue of white wine products maintained a good momentum. But due to the impact of macroeconomy, fluctuations in consumer market in the PRC, as well as increase in marketing and promotion expenses, the Group's revenue for the first half of 2025 decreased by 9% to approximately HKD 123 million compared to the same period in 2024. Profit attributable to owners of the Company declined by 56% to approximately HKD 8.2 million year-on-year. Basic earnings per share were approximately HK0.58 cents per share. The overall gross profit margin increased to 39% from 36% for the corresponding period in 2024, mainly due to optimisation of product mix during the period.Sales of white wines products of the Group served as the Group’s primary revenue contributor during the period. Sales revenue of red and white wines products accounted for approximately 41% and 54% of the Group’s overall revenue respectively for the period. During the period, the gross profit margin of red wine products and white wine products were 38% and 39% respectively.The Group has been actively pursuing innovation, embracing the “5+4+N” product strategy, with “N” standing for developing various customised products and continuously creating new products to meet the diverse needs of different Chinese consumer groups. During the period under review, the Group continued launching new products and carrying out product upgrade, that can better suit different palates, and cater for consumers with different spending power. That was done with an aim to invigorate the brand, as well as consolidating the image of Dynasty representative of domestic grape wine brand. The Group produced a wide range of more than 100 wine products under the “Dynasty” brand to meet the demands and preferences of different consumer groups mainly in the mass-market segments in the PRC wine market. During the period under review, the Group launched a new high-end product, i.e. Dynasty Chinese Zodiac Commemorative Dry Red Wine for the Yi Si Year of Snake, integrating with the Chinese zodiac culture and the leading rise of Chinese style fashionable products, by presenting the zodiac culture in a youthful visual language to attract potential consumers. During this period, the Group continued strengthening cooperation with the Wine Association and carried out activities such as "Dragon University Tours" to further expand the brand's awareness and reputation among young people. Based on its existing high-quality products, the Group continues to introduce new products and promote product upgrades. The Group participated in the 112th China Food & Drinks Fair in March 2025, introducing new products such as Tianyang Tea-flavoured wine series, Dynasty Baifu VSOP brandy, etc., to further improve its product matrix and provide consumers with diverse consumption choices. Breaking through from the constraints of traditional wine, this tea-flavoured wine series, with its core concept of "tea and wine fusion", has captured market attention with its unique craftsmanship. Based on white wine, this Tea-flavoured wine infuses the aromas of jasmine and Pu'er tea, creating a new oriental flavour within the traditional sparkling wine landscape. During the China Food & Drinks Fair, the Group also held wine-tasting events, where the new wines from Dynasty Tianxia Winery won industry praise for their unique flavor and exquisite craftsmanship.Further to our commitment to core wine business in the PRC, the Group will develop new alcoholic beverages segments such as sauce-flavour baijiu, yellow wine and special yellow wine – Chenpi wine, through the newly set up joint venture companies, so as to diversify the sources of revenue. Dynasty sauce-flavour baijiu products, namely ‘Han’, ‘Tang’, ‘Song’ and ‘Ming’ have been newly launched in Tianjin core-market with enthusiastic responses and will be further strategically promoted to other regions in the second half of the year. The sauce-flavour baijiu products satisfy the needs of customer groups with different spending habits and contributing to the Group’s business. In the future, the continuous development and expansion of the sauce-flavour baijiu industry and the improvement of the level of customer groups will inevitably and effectively drive the increase in the sales of Dynasty wine and related products, thereby enhancing our industry influence and brand awareness. For the yellow wine project, after planning, a manufacturing plant with a tank capacity of 3,000 tonnes of yellow wine and special yellow wine – Chenpi wine in Jiangsu will be under construction in the second half of 2025. Upon completion of the construction works, the Group will be able to produce special yellow wine – Dongtai Chenpi Wine which allows the Group to effectively expand product categories, seize development opportunities in the Chinese yellow wine industry, and achieve a major strategic move towards high-quality development of the wine industry.Regarding E-commerce sales, the e-commerce team of the Group comprehensively operated online stores on traditional e-commerce platforms, such as JD.com, Tmall and Pinduoduo for product sales, as well as comprehensive innovation on its brand, product categories, and business systems, procedures and models via interest-based ecommerce platforms, including RED, Kuai and TikTok during the period under review. The Group’s autonomous brand communications could continue to gain the attention of mainstream consumer groups and demographic segments, and enhance effective market penetration of the Group’s products targeted at young consumers. The e-commerce team also actively cultivate e-commerce live broadcasting talents to further expand its sales channels so as to build up a new customer base.In addition, during the period under review, the Group had boasted brilliant results in major wine appraisal competitions. Among the numerous awards, “Dynasty Jin. Y Brandy XO barrel-aged 12 years” has won the Silver Award, at the 2025 International Wine & Spirit Competition (“IWSC”). The competition is considered the international standard for wine and spirits quality. Dynasty Baifu VSOP Brandy, Golden Dynasty Marselan Dry Red Wine, as well as Tianyang Tea-flavoured Wine series are also awarded at the “2024 Qingzhuo Awards” in respective categories by China Alcoholic Beverages Association. “Dynasty Mengyuan White wine” has also won the Grand Gold Medal at the France International Wine Awards (“FIWA”) China region, Spring 2025 for its excellent quality. In addition, “Dynasty Inherit series -Dry Red Wine” has garnered the Gold Award at the same competition. These wines stood out from other entries for their elegant aroma, smooth body and round taste, and won the awards at the competitions, showing the charm and strengths of Dynasty wines to the country and the world.Mr. Wan Shoupeng, Chairman of Dynasty, concluded, “Looking ahead to the second half of 2025, the Group will continue to focus on market and consumer demand and promote product quality through technological innovation. At the same time, the Group will continue to innovate marketing strategies to stimulate brand vitality, further expand the market share of Dynasty’s products, strengthen Dynasty’s brand image representative of domestic wines, and set a benchmark for the Chinese wine industry, with the aim of bringing Dynasty’s superior wines to more consumers in the PRC. The Group will continue to proactively develop new marketing prospects through innovation in product categories and consumption scenarios, and cross-industry co-operations in order to boost sales volume, which is in line with the country’s effort to promote domestic consumption and release the consumption growth potential.”About Dynasty Fine Wines Group LimitedDynasty Fine Wines Group Limited was listed on the Main Board of The Stock Exchange of Hong Kong Limited with the stock code 00828 on 26 January 2005. Founded in 1980, Dynasty is the premier grape winemaker in China. It is principally engaged in the production and sale of grape wine products under its reputable “Dynasty” brand. Dynasty is the first Sino-foreign joint venture wine company in China with Tianjin Food Group Limited and the French grape wine giant, Remy Cointreau, as its current major shareholders. The Group produces and sells more than 100 grape wine product series, and introduces imported wine products, providing high-quality and value-for-money grape wines to the full range of consumer groups in China. Copyright 2025 ACN Newswire via SeaPRwire.com.

Healthy pipeline, diversification and cost discipline position the Company for long-term growthKey Financial Performance Highlights for the Financial Year (FY2025):- Group’s total revenue for the financial year is RM222.7 million, mainly driven by the e-mobility and energy storage segment, supplemented by the electronics segment.- Recorded LAT of RM40.9 million for Q4FY2025 and LAT of RM27.2 million for the financial year.BANGI, Malaysia, Aug 28, 2025 - (ACN Newswire via SeaPRwire.com) - Technology leader in providing turnkey, intelligent manufacturing automation solutions, Genetec Technology Berhad (“Genetec” or the “Company”), today announced its financial results for the year ended 30 June 2025 (“FY2025”). The Company reported a gross profit of RM12.7 million for FY2025, supported by continued deliveries in the e-mobility and energy storage segments. The Company recorded a loss after tax (LAT), mainly reflecting higher logistics costs and non-operational, one-off expenses, while underlying fundamentals remain intact.Performance was affected by logistics constrains and one-off costs. Despite this, the Company continued to invest in strengthening its capabilities and supporting future project scopes. Profitability is expected to normalise in FY2026 as markets stabilise and as projects are executed effectively. Genetec is also reinforcing its organisation by bringing in experienced professionals into strategic roles, aimed at broadening capabilities and supporting its long-term diversification strategy.Healthy Orderbook through Diversified MarketsThe Company’s order and tender books remain intact and healthy, underpinned by recurring orders from existing clients as well as new opportunities from a more diversified client base across multiple industries and regions.Deepening Engagement with Existing ClientsAlongside diversification, Genetec continues to strengthen partnerships with its existing clients. Recurring orders and new programme awards reflect the trust and confidence these clients place in Genetec’s execution capabilities and proven track record.Global Manufacturing Trends Creating TailwindsGlobal geopolitical shifts are leading manufacturers across industries to re-evaluate their production footprints and enhance operational resilience. This trend is fuelling greater demand for automation solutions that are flexible, cost-competitive, and consistently high in quality. With its Malaysia-based production model, strong international track record, deep technical know-how, and agile manufacturing capabilities, Genetec is well-positioned to support clients as they navigate and adapt to these evolving requirements.Positive Outlook for BESS PipelinesThe Battery Energy Storage System (BESS) segment continues to gain momentum, with Genetec executing projects across domestic and international markets, and seeing growing local interest in BESS solutions for peak shaving following the recent tariff revision.Chief Executive Officer and Co-founder of Genetec, Chin Kem Weng commented, “FY2025 was a year of investment and transition. We made deliberate strategic choices to strengthen our foundation, safeguard delivery timelines, and support new project scopes. While these factors impacted margins in the short term, they reinforce our capabilities and credibility as a trusted partner. We expect profitability to normalise as market stabilise and as we build on execution experience.”“At the same time, our pipelines remain healthy, supported by recurring orders from existing clients and new opportunities across diversified industries and regions. Our inclusion in both the conventional and Shariah FTSE4Good Bursa Malaysia indices reflects the strength of our governance and sustainability practices. As Genetec approaches our 30th year in business, we remain committed to creating long-term value for clients, shareholders, and stakeholders.”About Genetec Technology BerhadGenetec Technology Berhad is a public listed company on the Main Market of Bursa Malaysia Securities Berhad (Stock code: 0104) and a global leader in providing customised, turnkey smart factory automation solutions. With a strong international footprint, it serves a diverse range of industries including electric vehicle (EV), e-mobility and energy storage, automotive, hard disk drives (HDD), consumer electronics, appliances, and pharmaceuticals.For more information please visit: https://genetec.net/.Issued on behalf of Genetec Technology Berhad by Narro CommunicationsFor media enquiries on Genetec Technology Berhad, please contact:Farah Shahrul Narro Communications E: farah@narrocomms.com Joyce ShaminiNarro CommunicationsE: joyce@narrocomms.com Copyright 2025 ACN Newswire via SeaPRwire.com.

佛罗里达州西棕榈滩, 2025年8月28日 - (亚太商讯 via SeaPRwire.com) - U.S. Polo Assn.是美国马球协会（United States Polo Association, USPA）的官方运动品牌，现已达成多年合作协议，成为棕榈滩马拉松的新任冠名赞助商。由 Ken Kennerly 的 K2 Sports Ventures 拥有并运营的 U.S. Polo Assn. 棕榈滩马拉松，将于 2025 年 12 月 13-14 日在佛罗里达州西棕榈滩市中心举行。美国马球协会马拉松这项享有盛誉的马拉松赛事因其美丽的滨水景观和椰林大道而闻名，吸引来自全美乃至世界各地的跑者，在寒冷的冬季感受佛罗里达的温暖。该赛事同时也是享有盛名的波士顿马拉松的资格赛。USPA Global 总裁兼首席执行官 J. Michael Prince 表示：“U.S. Polo Assn. 很荣幸能够成为棕榈滩马拉松的冠名赞助商。这是一项标志性的赛事，就像我们的品牌一样，深深植根于充满活力的棕榈滩县社区。尽管我们这一个受运动启发的品牌已经在全球 190 多个国家拥有广泛的影响力，但我们的核心与传承正是在棕榈滩。这里是 USPA Global、美国马球协会以及全球最具声望的马球胜地——USPA 国家马球中心的所在地。”赛事周末活动将于 12 月 13 日（星期六）上午 7:30 举行 5 公里和 10 公里赛，随后在 12 月 14 日（星期日）上午 6:00 举行主赛事，包括马拉松、半程马拉松以及马拉松接力赛。目前已开放早期报名：马拉松报名费为 130 美元，半程马拉松为 100 美元；10 公里早期报名费为 60 美元，5 公里为 45 美元。报名请访问 palmbeachmarathon.com。健康与健身博览会（Health and Fitness Expo）将与选手领取参赛包同时进行，时间为 12 月 12 日（星期五）中午 12:00 至下午 6:00，以及 12 月 13 日（星期六）上午 10:00 至下午 6:00，地点在西棕榈滩 Datura 街 104 号的 Meyer Amphitheatre。博览会将展示最新的健康与健身产品和服务、跑步装备，以及未来赛事相关资讯。Kennerly 表示：“我们非常高兴能迎来像 U.S. Polo Assn. 这样享誉全球的品牌成为棕榈滩马拉松的冠名赞助商。这对赛事的未来以及其对全球跑者的吸引力来说，都是一件极其重要的事情。棕榈滩是全球公认的一流目的地，我们期待着赛事不仅能在本地社区持续发展，同时也能在国际舞台上不断壮大。”U.S. Polo Assn. 品牌产品涵盖男装、女装、童装，以及配饰、行李箱、手表、鞋履、家居用品等，并通过独立零售店、百货商店、U.S. Polo Assn. 品牌专卖店以及电子商务渠道，在全球 190 个国家进行销售。Prince 补充道：“与棕榈滩马拉松的合作，让我们能够共同庆祝体育卓越、社区精神、健康与福祉，以及那份将我们在本地与全球相连的运动热情。从马球赛场到棕榈滩的街道，我们从全力以赴的运动员身上汲取灵感，并期待能共享那份激情、友谊以及世界级竞赛氛围，这正是棕榈滩马拉松的独特魅力所在。”本次赛事还将支持即将公布的本地慈善项目。由赫斯特（Hearst）集团旗下的 ABC 联盟台 WPBF 25 将继续担任赛事官方转播电视台，不仅会在赛前和赛后通过所有电视频道和数字平台进行广泛报道，还将在马拉松比赛当天上午进行现场直播。WPBF 25 总裁兼总经理 Caroline Taplett 表示：“WPBF 25 非常高兴能够连续第二年担任 U.S. Polo Assn. 棕榈滩马拉松的官方转播电视台，这再次体现了我们致力于将这样一项独特而激动人心的赛事带给社区的承诺。与我们出色的合作伙伴 Ken Kennerly 及马拉松团队携手，我们将全力推动社区联系更加紧密，支持本地企业，并激励来自本地、全国乃至全球的参赛者齐聚美丽的南佛罗里达，共同参与这场独一无二的体验。”关于 U.S. Polo Assn. U.S. Polo Assn. 为美国马球协会（USPA）之官方品牌，该协会创立于 1890 年，是北美最大马球俱乐部与马球运动员联盟。今年，U.S. Polo Assn. 与美国马球协会（USPA）共同庆祝品牌成立 135 周年，持续从体育汲取灵感。 该品牌在全球范围内赞助大型马球赛事，其中包括每年在棕榈滩 USPA 国家马球中心（NPC）举行的 美国马球公开赛®（U.S. Open Polo Championship®），这是美国最顶级的马球赛事。U.S. Polo Assn. 拥有数十亿美元的全球品牌价值，并透过逾 1,100 间品牌零售店及数千个销售据点，在全球超过 190 个国家提供男装、女装、童装、配件与鞋类产品。透过与美国 ESPN、欧洲的TNT和印度 Star Sports 的历史性协议，U.S. Polo Assn. 赞助的多项世界顶级马球赛事首次转播至全球数百万体育迷，让这项激动人心的运动登上世界舞台。据《License Global》报导，U.S. Polo Assn. 长期被评为全球顶尖体育授权品牌之一，与 NFL、PGA Tour 和 Formula 1 并列。此外，该品牌亦因于全球及数位市场的成长，获得多项国际奖项肯定。 U.S. Polo Assn. 曾登上《富比士》、《财富》、《现代零售》和《GQ》等主流媒体，也多次出现在 Yahoo Finance 与 Bloomberg 等财经平台。关于 U.S. Polo Assn. 棕榈滩马拉松U.S. Polo Assn. 棕榈滩马拉松是一项顶级的冬季长跑赛事，每年在西棕榈滩举行，设有多种赛程，适合各类跑者参加，包括全程马拉松、半程马拉松、10 公里、5 公里以及四人马拉松接力。赛事路线为 100% 平坦且经 USATF 认证，并具备波士顿马拉松资格赛资格。赛道风景优美，跑者不仅能体验充满活力的西棕榈滩市中心，还能沿着棕榈树成荫的 Flagler Drive 前行，途经历史街区，并欣赏到闪耀的滨水景观。该赛事同时也支持社区和慈善事业。详情请访问 palmbeachmarathon.com 。联络资讯Stacey KovalskyU.S. Polo Assn. skovalsky@uspagl.com(954) 673-1331Gary FermanSpecialty Sports(954) 558-5203来源: U.S. Polo Assn. Copyright 2025 亚太商讯 via SeaPRwire.com.

香港，2025年8月28日 - (亚太商讯 via SeaPRwire.com) - 商汤集团股份有限公司（"商汤集团"或"公司"，股份代号：0020）今日公布截至2025年6月30日止半年度（"2025年上半年"）的中期业绩。2025年上半年，商汤集团业绩超出市场预期，总收入按年增长36%，达人民币24亿元；其中，生成式AI收入连续第三年高速增长，增幅达73%；经调整亏损净额按年和按月均大幅收窄，按年下降50%；贸易应收回款额32亿元，以96%大幅提升，达历史新高。截至2025年上半年，集团的总现金储备132亿元。2025年上半年，商汤持续深化"1+X"战略并取得实质性进展，完成业务动能稳健和结构优化。"1+X"以生成式AI与视觉AI作为"1"的核心业务，亦是双引擎，而"X"代表的X创新业务板块以孵化创新生态为核心战略，聚焦智能驾驶、智慧医疗、家用机械人、智慧零售等四个赛道。生成式AI占集团收入进一步提升至77%，日日新大模型多模态能力跻身世界前沿，大模型应用围绕"生产力工具"和"互动工具" 两大场景，快速提升渗透率和客户忠诚度。当中生产力工具以商汤"小浣熊"产品为代表，提供金融、教育、政务三大版本，用户数突破300万。在互动工具领域，"日日新 V6.5"实现了文本与音视频融合，多模态实时互动时数年内增长510%。视觉AI重启增长曲线，以高质量客户策略和领先市场占有率，实现利润空间与现金流双向改善。截至2025年6月底，视觉AI板块服务国内外客户660余家，复购比例57%，上半年海外商机储备与新订单按年显著增长。组织上，围绕"1"和"X"进行二次联合创业，形成专业化与多元化兼备的领导架构，针对创新业务任命独立的联创团队，实现"X创新业务"在战略重组后释放经营活力与资本市场吸引力。商汤科技董事长兼首席执行官徐立博士表示："在国务院发布《关于深入实施"人工智能+"行动的意见》重要举措的背景下，商汤紧抓落地机遇，深耕行业领域，以生成式AI与视觉AI为双引擎，使商汤在继续保持视觉AI龙头地位基础上，抓住生成式AI 所带来的历史性窗口，为员工、客户和股东持续创造价值。"2025年上半年集团核心经营亮点- 整体收入按年增长36%，达到24亿元人民币，增速较往年进一步提升；经调整EBITDA与经调整净亏损显著改善，按年收窄幅度分别达72.5%和50%；- 应收款回款金额创历史新高，达32亿元人民币，按年增长96%；贸易应收周转天数同比缩短49%；- 经营活动现金流净流出按年大幅收窄82%，现金创造能力不断增强；总现金储备攀升至132亿元人民币，为集团聚焦长期战略实施提供了充裕的资金保障。关于商汤作为人工智能软件公司，商汤科技以"坚持原创，让AI引领人类进步"为使命，旨在持续引领人工智能前沿研究，持续打造更具拓展性更普惠的人工智能软件平台，推动经济、社会和人类的发展，并持续吸引及培养顶尖人才，共同塑造未来。商汤科技拥有深厚的学术积累，并长期投入于原创技术研究，不断增强行业领先的多模态、多任务通用人工智能能力，涵盖感知智能、决策智能、智能内容生成、自然语言处理等关键技术领域，同时包含AI芯片、AI传感器及AI算力基础设施在内的关键能力。此外，商汤前瞻性打造新型人工智能基础设施——商汤AI大装置SenseCore，打通算力、算法和平台，并在此基础上建立"商汤日日新SenseNova"大模型及研发体系，以低成本解锁通用人工智能任务的能力，推动高效率、低成本、规模化的AI创新和落地，进而打通商业价值闭环，解决长尾应用问题，引领人工智能进入工业化发展阶段。商汤科技业务涵盖生成式AI、视觉AI和X创新业务，相关产品与解决方案深受客户与合作伙伴好评。商汤倡导"发展"的人工智能伦理观，并积极参与有关数据安全、隐私保护、人工智能伦理道德和可持续人工智能的行业、国家及国际标准的制订，与多个国内及多边机构就人工智能的可持续及伦理发展开展了密切合作。商汤《AI可持续发展道德准则》被联合国人工智能战略资源指南选录，并于2021年6月发表，是亚洲唯一获此殊荣的人工智能公司。目前，商汤科技已于香港交易所主板挂牌上市。商汤在香港、上海、北京、深圳、成都、杭州、西安、新加坡、曼谷、吉隆坡、利雅得、阿布扎比、杜拜、首尔等地设立办公室。另外，商汤科技在德国、泰国、印尼、菲律宾等国家均有业务。更多资讯，请浏览商汤科技网站、微信、微博和领英。 Copyright 2025 亚太商讯 via SeaPRwire.com.

财务摘要 (未经审核)（港币千元）截至六月三十日止六个月2025年2024年收入122,775135,347毛利47,27748,767本公司所有者应占溢利8,17218,510毛利率39%36%每股基本盈利 (港仙)0.581.31香港，2025年8月28日 - (亚太商讯 via SeaPRwire.com) - 中国优质葡萄酒生产商王朝酒业集团有限公司（「王朝」或「集团」）（股份代号：00828）今日公布截至2025年6月30日止未经审核之中期业绩。2025年上半年，由于集团加强沿海地区干白酒市场的开拓力度，推出新的白葡萄酒及起泡葡萄酒产品，集团白葡萄酒产品的销售收入保持良好势态。但受中国宏观经济及消费市场波动的影响，集团产品（尤其是高端葡萄酒产品）销量下跌，以及由于推广及宣传开支增加，集团2025年上半年收入较2024年同期下跌9%至约1.23亿港元，本公司所有者应占溢利较2024年同期减少56%至约8.2百万港元，每股基本盈利约为每股0.58 港仙。期内由于产品组合优化，集团毛利率由去年同期的36%上升至39%。集团白葡萄酒产品的销售于期内为集团的主要收益贡献来源。红葡萄酒与白葡萄酒产品的销售收入分别占集团整体收入约41%及54%。期内，红葡萄酒产品和白葡萄酒产品的毛利率分别为38%及39%。本集团积极求新，聚焦「5+4+N产品战略」，其中「N」代表集团推出N项需求定制，不断开拓创新产品，以满足中国不同类型消费群体的多元化需求。于回顾期内，本集团继续推出新产品及进行产品升级，以更好地满足不同葡萄酒口味及不同消费能力的消费者，旨在激发品牌活力，并巩固王朝作为国产葡萄酒代表的品牌形象。本集团以「王朝」品牌产销超过100种葡萄酒产品，迎合中国葡萄酒市场大众市场分部不同消费者群的各项需求和喜好。于回顾期内，本集团推出中高端新品－王朝乙巳蛇年生肖纪念干红葡萄酒，与中国生肖文化相融合，引领「国潮风」，以年轻化的视觉语言呈现生肖文化，吸引潜在消费者。于本期间，本集团持续加强与酒业协会的合作，开展「龙行高校」等活动，进一步扩大品牌在年轻族群中的认知度与美誉度。基于其现有的优质产品，本集团继续推出新产品并推进产品升级。本集团于二零二五年三月在第112届全国糖酒商品交易会上推出天阳茶酒系列、王朝百馥VSOP白兰地等新品，以进一步完善其产品矩阵，为消费者提供多元的消费选择。该系列茶香葡萄酒突破传统葡萄酒的局限，以「茶酒融合」为核心理念，凭借独特的酿造工艺迅速获得市场目光。这款茶香葡萄酒以白酒为基调，融合茉莉花及普洱茶的芬芳，在传统的气泡酒领域中，创造出一种全新的东方韵味。在全国糖酒商品交易会期间，本集团亦举办品酒会，王朝天夏酒庄的新品凭借独特的风味和精湛的酿造工艺，赢得业界的好评。除致力于中国核心葡萄酒业务外，本集团亦将通过新设立的合资公司，拓展新的酒类饮料领域，如酱香型白酒、黄酒及特种黄酒－陈皮酒，以实现收入来源的多元化。王朝酱香型白酒产品，即「汉」、「唐」、「宋」、「明」，已于天津核心市场新推出并得到热烈回响，并将于下半年进一步战略推广至其他地区。酱香型白酒产品满足不同消费习惯的客户群体的需求，并为本集团业务作出贡献。未来，酱香型白酒产业的发展及扩张及客户群体水平的持久提升，必将有效推动王朝葡萄酒及相关产品销售的增长，从而提升我们的行业影响力及品牌知名度。对于黄酒项目，经规划后，正于二零二五年下半年在江苏建设一座储罐容量为3,000吨黄酒及特种黄酒－陈皮酒的生产厂房。于建设工程竣工后，本集团将能够生产特种黄酒－东台陈皮酒，让本集团可有效扩展产品品类，把握中国黄酒行业的发展机遇，实现酒业高质量发展的重大战略举措。电商销售方面，于回顾期内，本集团的电商团队于传统电商平台全面运营在线商店销售产品，例如京东商城、天猫商城及拼多多，以及通过兴趣电商平台（包括小红书app、快手app及抖音app）全面创新品牌、品类、业务体系、流程和模式。本集团的自主品牌传播使其可继续获得主流消费群体和圈子的关注，并提高本集团面向年轻消费者的产品的有效市场渗透率。同时，电商团队积极培养电商直播人才，以进一步扩大其销售渠道及建立新客户群。此外，于回顾期内，本集团在大型葡萄酒品鉴大赛中屡获殊荣。在多个奖项中，「王朝锦邑桶藏12年XO白兰地」荣获二零二五年国际葡萄酒与烈酒大赛（「IWSC」）中的银奖。该比赛被视为葡萄酒和烈酒质量的国际评价标准。王朝百馥VSOP白兰地、金王朝马瑟兰干红葡萄酒以及天阳茶酒系列亦于中国酒业协会举办的「二零二四年青酌奖」各类别评选中获奖。「王朝梦园白葡萄酒」亦以其卓越的酒质荣获二零二五年春季FIWA法国国际葡萄酒大奖赛中国区金奖。此外，「王朝传承系列－干红葡萄酒」于同一比赛中荣获金奖。该等葡萄酒因其酒香优雅、酒体顺滑和口感圆润从众多参赛作品中脱颖而出，并在比赛中获得奖项，向国家及世界展示了王朝葡萄酒的魅力和实力。王朝主席万守朋先生总结︰「展望二零二五年下半年，本集团将继续聚焦市场和消费者需求，并通过技术创新提升产品质量。同时，本集团将继续创新营销策略，激发品牌活力，进一步扩大王朝产品的市场份额，加强王朝品牌作为国产葡萄酒代表的形象，并为中国葡萄酒行业树立标杆，将王朝美酒风尚带给更多的中国消费者。本集团将继续通过产品品类及消费场景的创新，以及跨行业合作，积极开拓新的营销前景，以提升销量，藉此支持国家扩大内需及释放消费增长潜力的工作。」关于王朝酒业集团有限公司王朝酒业集团有限公司于2005年1月26日在香港联合交易所有限公司主板上市，股份代号00828。成立于1980年，王朝为中国优质葡萄酒生产商，主要生产及销售「王朝」商标的葡萄酒产品，是中国第一家中外合资的酿酒企业，主要股东包括天津食品集团有限公司及法国葡萄酒巨头人头马集团。集团产销葡萄酒产品系列超过100种，及引入进口葡萄酒产品，为国内各消费层提供高质素及物超所值的葡萄酒。 Copyright 2025 亚太商讯 via SeaPRwire.com.

香港，2025年8月28日 - (亚太商讯 via SeaPRwire.com) - 8月27日，澳优乳业股份有限公司（股份代号：1717.HK，以下简称"澳优"或"公司"）发布2025年上半年业绩公告。公告显示：2025年1-6月，澳优实现营业收入约人民币38.87亿元，同比增长5.6%；实现EBITDA（息税折旧及摊销前利润）约人民币3.98亿元，同比增长29.7%；归属于母公司权益持有人应占利润约人民币1.81亿元，同比增长24.1%，实现营收利润持续韧性双增长。公告表示，2025年上半年，面对复杂多变的全球经济形势及竞争加剧的中国婴配粉市场环境，澳优稳步推进"奶粉+营养品"全家营养战略，进一步打造产品力、品牌力、渠道力、数智力及组织力，在消费者的信任、社会各界的支持和全体澳优人的共同努力下，营收、利润继续保持双增长趋势，以坚韧不拔的毅力和稳健扎实的步伐迈向高质量发展新阶段。分版块看，澳优自有品牌奶粉业务实现整体营收约人民币28.26亿元。其中，羊奶粉业务实现收入18.65亿元，同比增长3.1%，"领头羊"地位持续稳固，尼尔森IQ数据显示截至6月底公司羊奶粉市场占有率同比提升2.8个百分点至30.4%；在2024年中国进口婴幼童羊奶粉市场销售量份额及销售额份额均高达84%，已连续7年在中国进口婴幼童羊奶粉市场份额超6成。【1】与此同时,弗若斯特沙利文经市场研究确认：2024年佳贝艾特羊奶粉销量与销售额全球第一。【2】牛奶粉业务实现收入约人民币9.61亿元,营养品业务实现收入同比增长7.0%，并成功拓展至海外市场。分区域看，2024年羊奶粉中国业务实现收入约人民币13.81亿元；羊奶粉国际业务实现收入约人民币4.83亿元，同比大幅增长65.7%，国际业务多点开花，实现爆发式增长，在公司自有品牌配方羊奶粉业务总收入的占比进一步提升至25.9%。公告显示，中东地区在2025上半年继续保持澳优海外最大销售市场的地位；北美地区收入同比提升逾138.7%，成为澳优海外市场第二大营收来源，独联体地区收入同比增长33.8%。澳优在公告中表示，羊奶粉业务海外市场在过去两年保持高双位数复合增长率的基础上，于上半年再攀高峰，实现同比增长65.7%；营养品业务战略布局全面起势，成为驱动公司发展的重要动力。数据来源：【1】尼尔森IQ进口婴幼童羊奶粉零售追踪数据；时间段：2018年-2024年，连续7个年度；渠道范围：上海、江苏、浙江、安徽、河南、广东、湖南、湖北、福建、江西、北京、天津、黑龙江、吉林、辽宁、山东、山西、河北、陕西、四川、重庆、贵州、云南、广西的城市母婴渠道。【2】弗若斯特沙利文Frost & Sullivan《全球羊奶粉市场独立研究报告》（2025年4月）。基于对全球羊奶粉市场的研究，对2024年全球范围内主要羊奶粉品牌的销量以及销售额进行研究分析后做出的确认，调研数据覆盖2024年1月至12月。 Copyright 2025 亚太商讯 via SeaPRwire.com.

- 华堂宁(R)销量同比增长108%，净销售额同比增长112%。医保覆盖持续扩大，二级和三级医院处方量显著增加，全面自主商业化成效显著。- 与拜耳终止独家推广服务协议后，确认一次性递延收入人民币12.435亿元，实现上半年盈利11.839亿元，公司在业绩期内首次实现盈利。- 在中国开展涉及80个中心和2000名2型糖尿病患者的真实世界研究，进一步证明多格列艾汀的广泛适用性和安全性。- 多格列艾汀75mg（商品名：MYHOMSIS(R)，華領片TM）在香港递交注册申请，加速布局大中华区及东南亚市场。- 毛利率显著提升，生产规模与运营效率持续优化。上海，2025年8月28日 - (亚太商讯 via SeaPRwire.com) - 华领医药（"公司"，香港联交所股份代号：2552）宣布公司及其附属公司截至2025年6月30日止六个月（"报告期"）未经审核的综合业绩，以及公司上半年业务进展与未来展望。报告期内，公司核心产品华堂宁(R)（多格列艾汀片）商业化加速，自主运营能力显著提升，研发进展顺利推进，财务表现实现突破性成长，为长期可持续发展奠定了坚实基础。华领医药创始人兼首席执行官陈力博士表示："2025 年上半年是华领医药转型发展的关键阶段。全面接管华堂宁(R)商业化后，公司凭借自主搭建的销售团队，实现了销量与收入的翻倍增长，印证了新的商业模式的有效性。我们还在中国香港递交了新药上市申请，为多格列艾汀从中国走向东南亚乃至全球市场奠定了基础。同时，多格列艾汀在真实世界研究中持续展现出广泛的治疗潜力，也在基础研究中发现了糖尿病缓解、认知改善、血脂改善和增肌等方面的新证据，进一步巩固了华领医药在GKA研发和治疗领域的全球领先地位。未来，华领医药将继续深耕糖尿病和整个代谢疾病领域，通过创新研发与市场拓展的双轮驱动，让中国原创新药惠及更多全球患者。"业务亮点与运营进展商业化转型成效显著，销售与利润双增长- 2025年1月1日起，公司终止与拜耳的独家推广服务协议，全面接管华堂宁(R)在中国的商业化运营。报告期内，在与2024年同期的单价保持一致的情况下，华堂宁(R)销量达176.4万盒，同比增长108%；净销售额达2.174亿元，同比增长112%。凭借强劲的商业执行力和不断提升的运营效率，公司迈向盈利。华领医药已顺利过渡到全面自主商业化阶段，也印证了日益增长的市场需求和自主销售团队的高效执行力。- 2024年被纳入中国国家医保药品目录(NRDL)后，2025年华堂宁(R)继续受益于广泛的医保覆盖，二级和三级医院的处方量显著增加，有助于提高患者的可及性和长期使用率。- 由于生产规模扩大和成本效率的提升，公司毛利率提升至54.2%，高于去年同期的46.5%。- 在销售额同比增长112%的情况下，报告期内公司销售费用为6420万元，与去年同期相比仅增长5%，报告期内销售费用约占总收入的29.5%，显著低于去年同期的59.5%。这是因为，2025年上半年销售费用构成与2024年同期相比发生了显著变化：由公司在中国承担华堂宁(R)的独家商业化责任而直接产生销售费用，而无需再向原商业化合作伙伴支付推广费用。这反映出公司显著的盈利向好趋势，也表明了公司的业务战略，即通过控制与华堂宁(R)商业化直接相关的销售费用，以及最大限度地提高生产效率，来优化盈利能力。- 与拜耳终止独家推广服务协议后，公司确认一次性递延收入12.435亿元，向自主驱动增长转型。华领医药首次实现半年税前利润11.839亿元，这是华领医药迈向可持续盈利的关键里程碑。- 截至2025年6月30日，现金余额为10.228亿元，为公司未来的研发和商业化举措奠定了坚实基础。临床研究持续深入，新证据支撑治疗潜力- 公司正在推进多项上市后研究，以评估多格列艾汀在不同患者群体中的长期安全性和有效性，包括单药治疗以及与其它已经获批的热门降糖药，如GLP-1受体激动剂、胰岛素、DPP-4抑制剂和SGLT-2抑制剂的联合用药。这些研究正在为血糖控制、认知改善和糖尿病缓解潜力等提供新的临床依据。- 公司正在开展多格列艾汀上市后真实世界研究（BLOOM），在全国80家中心纳入2000例2型糖尿病患者，目前已完成1000余例患者的1年随访。在真实世界环境中，BLOOM研究进一步证明了多格列艾汀的广泛适用性和安全性。在临床用药中，接受多格列艾汀治疗的患者往往存在多种合并症，包括各种心血管和肾脏疾病等，并且正在接受多种伴随药物治疗。除二甲双胍外，超过60%的患者在使用多格列艾汀的同时，还联合使用了SGLT-2抑制剂、胰岛素、GLP-1受体激动剂或DPP-4抑制剂等其它降糖药。无论是单药治疗还是联合用药，多格列艾汀普遍表现出良好的耐受性，安全性特征也与先前的临床研究数据保持一致。- 在2025年美国糖尿病协会（ADA）科学年会上，公司公布了多格列艾汀的新研究数据，进一步阐明其作为疾病修饰疗法的作用机制，关于多格列艾汀作为GKA药物的新作用机制的相关成果已发表于《糖尿病》（Diabetes）杂志上。研发管线与未来展望- 公司已在中国香港提交多格列艾汀75mg（商品名：華領片TM，MYHOMSIS(R)）的注册申请，旨在扩大在大中华区和东南亚的业务版图。- 公司正在通过开发二甲双胍和多格列艾汀的固定复方制剂拓展产品管线，用于服用高剂量二甲双胍（>每日1500mg）仍无法控制血糖的患者，此前的DAWN临床研究显示，多格列艾汀联合二甲双胍用药可使患者的糖化血红蛋白（HbA1c）降低超过1%，餐后血糖降低超过5mmol/L，低血糖发生率仅为0.8%。该血糖控制水平表明，多格列艾汀-二甲双胍固定剂量复方制剂作为口服降糖药具有强大的潜在需求。2025年8月，公司已完成IND前资料提交，预计于2026 年初启动生物等效性（BE）研究。- 通过收集真实世界证据以及在动物模型中开展概念验证研究，公司正在推进多格列艾汀与GLP-1受体激动剂、DPP-4制剂和SGLT-2抑制剂的联合用药。多格列艾汀与这些药物之间的协同作用有望将其适应症扩展到肥胖症、代谢相关脂肪性肝炎（MASH）等其它代谢紊乱疾病领域。- 公司将继续加强与国际领先的研究机构的合作。由华领医药支持的一项研究者发起的I 期临床研究正在宾夕法尼亚大学进行，旨在评估多格列艾汀在囊性纤维化相关糖尿病（CFRD）患者中的疗效和安全性，该试验已获得美国食品药品监督管理局（FDA）的批准。- 公司将继续致力于开发糖尿病预防、代谢紊乱相关神经退行性疾病领域的治疗机遇，最终找到一种新的方法来延长人类的健康寿命。- 公司将继续投资于数字技术平台，以在各个职能部门之间创造协同效应，并利用人工智能技术提升品牌机遇。- 公司将继续自主推进多格列艾汀和第二代GKA的研发，并与学术和战略合作伙伴共同开展相关工作。公司正在推进多格列艾汀在香港的注册，并继续在东南亚和"一带一路"国家寻求合作伙伴。基于美国I期单剂量递增研究的初步成功，公司计划于2025年底或2026年初启动多剂量递增I期研究，从而继续推动第二代GKA在全球市场的业务发展。财务摘要截至2025年6月30日- 公司银行结余及现金约人民币10.228亿元- 总营收约2.174 亿元，同比增长112%，华堂宁(R)销量达176.4万盒，同比增长108%- 毛利约1.178亿元，同比增长147%，毛利率约54.2%，同比增长7.7个百分点- 其他收入约12.546亿元，其中拜耳一次性递延收入为12.435亿元- 总开支约1.871亿元，其中研发开支约6580万元- 税前利润约11.839亿元，同比增长932%前瞻性声明本文包含有关华领医药以及产品未来预期、计划和前景的陈述。该等前瞻性陈述仅与本文作出该陈述当日的事件或资料有关，可能因未来发展而出现变动。除法律规定外，于作出前瞻性陈述当日之后，无论是否出现新资料、未来事件或其他情况，我们并无责任更新或公开修改任何前瞻性陈述及预料之外的事件。请仔细阅读本文并理解，由于各种风险、不确定性或其他法定要求我们的实际未来业绩或表现可能与预期有重大差异。关于华领华领医药（"本公司"）是一家总部位于中国上海的创新药物研发和商业化公司，在美国、中国香港设立了公司。华领医药专注于未被满足的医疗需求，为全球患者开发全新疗法。华领医药汇聚全球医药行业高素质人才，融合全球创新技术，依托全球优势资源，研究开发突破性的技术和产品，引领全球糖尿病医疗创新。公司核心产品华堂宁(R)（多格列艾汀片）以葡萄糖传感器葡萄糖激酶为靶点，提升2型糖尿病患者的葡萄糖敏感性，改善患者血糖稳态失调。2022年9月30日，华堂宁(R)已获得中国国家药品监督管理局（NMPA）的上市批准，用于单独用药或者与二甲双胍联合用药，治疗成人2型糖尿病。对于肾功能不全患者，无需调整剂量，是一款可用于肾功能损伤的2型糖尿病患者的口服降糖药物。详情垂询华领医药网址：www.huamedicine.com投资者电邮：ir@huamedicine.com媒体电邮：pr@huamedicine.com新闻免责声明本材料，如为上下文论述的准确性和完整性，提及在中国上市的产品相关信息的，特别是标识或要求，应遵循中国监管机构批准的相关文件。另外，相关信息不应被解读为对任何药物或者诊疗方案的推荐或者宣传，亦不应替代任何医疗卫生专业人士的医疗建议，涉及医疗的相关事宜务必咨询医疗卫生专业人士。 Copyright 2025 亚太商讯 via SeaPRwire.com.

香港，2025年8月28日 - (亚太商讯 via SeaPRwire.com) - 碧瑶绿色集团有限公司（「碧瑶」或「集团」；股份编号：01397.HK）欣然宣布截至2025年6月30日止六个月（「期内」）之未经审核之中期业绩。期内，集团收益约13.5亿港元，较去年增加约4.8%。整体毛利率由去年同期7.5%增加至9.8%，带动整体毛利增加约37.0%，至约1.3亿港元。期内溢利约为5千9百万港元，较去年同期增加约128.1%。业务回顾及展望清洁作为集团的核心业务，继续于期内录得增长，收益相比去年同期增加4.0%，至约10.8亿港元，占集团总收益约79.6%。清洁业务毛利率由去年同期6.4%增加至7.9%，带动毛利增加27.4%，至约8千5百万港元，主要由于集团与政府各部门及不同机构的新清洁服务合约所致。集团的清洁服务涵盖不同场景，包括为政府辖下街道、街市、康乐场地、医院及诊所提供清洁服务。其他清洁场地遍及各大学、大型展览中心、香港国际机场、屋苑及私人机构等众多不同场所。废物管理及回收方面，期内收益为约1.5亿港元，占集团总收益约10.7%。废物管理及回收业务的毛利率由去年同期12.9%，大幅增加至19.2%，拉动该业务毛利上升约46.6%，至约2千8百万港元，主要受惠于政府积极推动回收，大幅扩展包括厨余的回收点网络，便利市民参与并有效刺激收集量及绿色科技业务所带动。集团继续为政府辖下的五区提供废物收集服务，服务人口约160万。回收方面，集团作为政府环境保护署（「环保署」）服务承办商，为香港数千个回收点提供收集服务（包括塑胶、玻璃樽、金属、废纸及厨余）。集团于期内为公共场所及学校的回收箱，提供收集服务。此外，碧瑶亦为香港众多环保署辖下的「绿在区区」回收环保站、回收便利点、智能回收机及不同机构，提供回收服务。另外，碧瑶为政府于香港多区负责玻璃容器收集及处理，以及厨余收集，为市场领导者之一。绿色科技业务方面，集团赢得新合约，为政府供应新一代太阳能废物压缩箱。此创新产品设计具有自动感应投入口及指示灯，在密封式设计下加装通风、照明及除臭等装置。同时配备大数据平台及无线技术实时监控数据，有效追踪废物收集点的状态，策略地部署资源，优化运作效率，并加强对未来措施的规划。此外，太阳能废物压缩箱采用光伏板，依靠可再生能源，大大减低碳排放，可灵活配置于不同场景，适合没有垃圾收集站的偏远地区。此产品预计于年内陆续推出市场。集团把握智慧城市发展的契机，近年致力扩大智能回收的市场份额。目前碧瑶智能回收产品，例如：智能回收机、智能厨余回收机及智能磅等已遍及香港不同角落，包括各政府场地及学校、私人屋苑、商业大厦、主题乐园、大型展覧及体育场馆等。每日24小时为市民提供便捷的回收体验，并有助提升香港整体回收量。集团与怡和机器有限公司合作位于香港屯门环保园的生物炭工厂，已开始营运，通过热解技术将园林废料转化为高质量生物炭以作各种应用，从而达到「转废为材」的目的。园艺方面，客户涵盖大型私人住宅、政府处所、学校、商场、酒店、机场、香港房屋委员会、香港赛马会、香港科学园、香港大学、香港科技大学及岭南大学等。集团期内为启德体育园、香港国际机场、港深创新及科技园、微型公园及东涌西新发展区提供园艺工程。虫害管理方面，集团期内继续为黄大仙区及大埔区提供虫害管理服务。此外，集团分别为古物古迹办事处辖下29个古迹及华人庙宇委员会辖下24间庙宇，提供白蚁防治及监测服务。截至2025年6月30日，集团的手头合约约31.0亿港元，为日后迎来可观的收益。集团于报告期后成功中标政府海事处一份为期三年总值约1.5亿港元的「香港东部水域海上垃圾清理及处理服务」合约。此合约标志着碧瑶的服务版图，成功由陆地策略性拓展至海洋，为集团业务发展的重要里程碑，进一步巩固其在香港综合环境服务市场的领导地位。根据合约，碧瑶将自2025年10月1日起，于香港东部水域（包括但不限于维多利亚港、中环、上环、铜锣湾、尖沙咀、油麻地、长沙湾、筲箕湾、观塘、西贡、吐露港及大埔等地区）提供全面的海上清洁及船只生活垃圾收集服务。获得此合约，代表市场充份肯定碧瑶成立45年来的卓越表现。集团将其陆上废物管理的专业标准与营运效率无缝延伸至海上，致力守护香港珍贵的海洋生态环境，为市民及旅客呈现一个更洁净、更美丽的维多利亚港。近日集团成功中标环保署两份为期35个月总值港币约4千3百万港元的合约。自2025年9月起，集团将负责营运「绿在太和」及「绿在宝琳」回收便利点，以及与邻近大厦、机构及社区持份者合作，建立及营运固定及流动回收点进行收集，提供便利市民的社区回收支援，以及在社区推动和教育市民分类回收，强化市民回收习惯。此外，政府提交的《2025年促进循环再造及妥善处置产品（杂项修订）条例草案》于2025年7月23日获立法会通过，为生产者责任计划订立适用于不同产品的共同法律框架。在此框架下，政府计划于明年提交有关塑胶饮料容器及纸包饮品盒生产者责任计划。此计划鼓励市民将使用完的容器交回作循环再造，从而获取回赠，有助大大增加回收率。受益于该计划，预计将直接拉动碧瑶回收量，为集团多年来于回收服务建设的投资及竞争壁垒，提供吸引回报。政府正全速发展北部都会区，其中四个新发展区，包括古洞北╱粉岭北、洪水桥╱厦村、元朗南及新田科技城已进入施工阶段。政府已经在四个新发展区收回逾400公顷私人土地，完成平整80公顷土地并陆续将这些土地交付部门兴建道路铁路基建、公私营房屋、学校、公众街市、生态保育，以至发展创科产业，相信为集团多个核心业务带来契机。展望未来，集团在致力提高各核心业务的市场份额的同时，积极于香港及以外地区扩张。同时因应公司的发展，适时寻找潜在的并购、合营、或新业务项目，加速未来业务增长，为股东缔造可观及长远回报。有关集团2025年度中期业绩公告详情，请浏览以下网址：https://www.baguio.com.hk/zh-hant/investor/notices/碧瑶绿色集团简介碧瑶绿色集团（股份代号：01397.HK）成立于 1980 年，为香港最大的综合环境管理方案供应商之一，提供环卫保洁、资源回收、循环再造、废物管理、绿色科技、绿色产品、园艺绿化工程及害虫防治等。集团应用最新科技，提供创新环境解决方案，为不同领域的客户提供服务，包括政府部门、各大机构及跨国企业。集团努力不懈地提升环境、社会及管治(ESG)的表现，以推进集团的可持续发展，为了更绿的明天，实现将香港推动成为更清洁、更绿色、更健康城市的愿景。 Copyright 2025 亚太商讯 via SeaPRwire.com.

香港，2025年8月28日 - (亚太商讯 via SeaPRwire.com) - 2025年8月，北京--首程控股有限公司（0697.HK，以下简称"首程控股"）、北京首程机器人科技产业有限公司（以下简称"首程机器人"）、阿尔特汽车技术股份有限公司（300825.SZ，以下简称"阿尔特"）、北京阿尔瑞特智能机器人科技有限公司（以下简称"阿尔瑞特"）正式签署战略合作框架协议。四方将充分发挥各自优势，围绕机器人产业的技术创新、应用落地、产业链协同与人才培养，展开全方位合作，推动"机器人+汽车"应用新业态加速发展。一、产业背景：机器人进入应用落地加速期当前，全球机器人产业正处于高速发展阶段，国家战略和政策密集出台。8月26日，国务院正式发布《国务院关于深入实施"人工智能+"行动的意见》（国发〔2025〕11号），明确提出要推动人工智能与经济社会各行业各领域的广泛深度融合，加快形成人机协同、跨界融合、共创分享的智能经济和智能社会新形态。在这一国家战略指引下，机器人产业正从"技术突破"迈向"应用落地"。汽车与机器人作为两个高度契合的产业，正逐渐呈现跨界融合趋势。此次首程控股与阿尔特集团的合作，将在政策东风与市场需求的双重驱动下，为机器人在研发、制造、交通和出行服务等关键环节的应用注入新动能。阿尔特是中国汽车设计领域的领军企业，也是A股市场唯一的独立汽车设计上市公司，具备整车研发设计与核心零部件制造的全流程服务能力，并践行"技术+供应链"的国际化战略。据公开信息，公司累计服务超80家客户，参与开发近500款车型，客户涵盖一汽、东风、北汽、吉利、新势力品牌与合资企业等主机厂类型。这意味着阿尔特在汽车产业链中拥有深厚的主机厂资源与交付能力。与此同时，阿尔特通过控股子公司--北京阿尔瑞特智能机器人科技有限公司，已正式开辟机器人新赛道。阿尔瑞特致力于打造一体化研发设计与仿真训练平台，能够为多场景机器人开发提供从仿真、测试到优化的全流程支撑；目前已启动轮式机器人、水下机器人、钻井机器人和宠物洗护机器人等多个研发项目，体现了其跨场景研发和产业协同的潜力。阿尔瑞特的加入，使本次合作不仅局限于传统汽车设计层面的协作，更在机器人研发、仿真与汽车产业化融合方面提供了重要支撑。与阿尔特及阿尔瑞特的合作，将帮助首程把机器人技术深度嵌入汽车产业链的核心环节，如整车制造、智能装配与产线测试，使机器人真正进入产线、加速产业应用。这一战略合作不只是一种技术对接，更是借助阿尔特在主机厂客户群体中的资源网络，将机器人场景从"隔壁展示"一步推向"生产车间"，连接研发验证与规模化交付的关键路径。二、合作重点：研发突破与应用落地并举在国务院"人工智能+"行动政策引领下，四方将立足"技术研发-产业应用-生态共建"全链条，协同推进产业创新，重点在以下方向开展合作，助力机器人与汽车深度融合：（一）技术创新与联合研发四方将联合建设机器人一体化研发与仿真平台，借鉴汽车行业的完整研发体系，重点在运动控制、结构优化、车规级零部件和规模化制造等关键环节实现突破。同时，依托NVIDIA Isaac/Omniverse技术，共同打造一体化仿真训练平台，不仅支持机器人在汽车研发、制造和测试中的应用模拟，还可开展智能驾驶车辆与物流机器人协同作业等跨场景模拟。双方还将建立数据与成果共享机制：首程控股提供来自交通、出行等运营环节的数据资源，阿尔特输出汽车工程和机器人研发经验，形成从仿真-研发-验证-产线应用的完整闭环。（二）优先采购与协同机制在研发设计、仿真训练、整机和零部件供应等环节，四方将实行优先采购机制，在同等条件下优先选择协议方为合作伙伴。首程控股与首程机器人重点提供产品推广、代理及配套服务；阿尔特与阿尔瑞特聚焦于技术研发、工程化验证和定制化整机开发。各方将协同推进机器人本体二次开发，确保机器人产品在汽车生产线、智能装配和产线检测等场景下实现最佳适配。通过分工协作，形成产品供给-技术创新-应用反馈的互补格局，加快成果转化，提升商业化效率。（三）人才培养依托首程、阿尔特及其合作伙伴的科研与产业平台，四方将联合开展技术攻关、仿真训练与应用试点，为科研人员和工程师提供跨行业、跨场景的实践环境。同时，定期举办技术研讨会和产业论坛，邀请行业专家和上下游企业参与，建立联合人才培养机制，打造一批兼具汽车工程背景与机器人产业化实践经验的青年科研人才，夯实长期发展的人才基础。（四）拓宽发展空间四方将深度对接国家"人工智能+"与机器人产业发展战略，重点推动"机器人+汽车"在研发、制造、测试和出行服务环节的规模化应用。在此基础上，合作还将逐步延展至智慧交通、智能制造、医疗健康、教育、公共服务等更广阔的领域，涵盖机器人及核心零部件的设计、研发、生产、测试和商业化服务。同时，结合资本与产业的联动，推动产业链上下游协同升级，最终形成从研发验证到规模化应用的全链条闭环，打造具有示范效应的"机器人+汽车"应用矩阵，实现互利共赢和长期价值创造。三、战略意义：打造机器人应用新标杆机器人产业的最大价值在于应用落地，而"机器人+汽车"正是最具潜力和爆发力的应用方向之一。从整车研发到智能制造，从交通调度到智慧出行，机器人将在汽车全产业链环节展现巨大价值。首程控股凭借资本平台、生态资源与产业基金优势，已投资宇树科技、银河通用、松延动力、星海图、加速进化等国内头部企业，具备前沿技术的整合能力；首程机器人则与上百家上下游优质企业建立合作，成为国内链接资源最全面的平台之一。阿尔特与阿尔瑞特则将汽车领域成熟的工程体系迁移至机器人研发与产业化。双方优势叠加，构建起"研发-迭代-应用-规模化"的完整路径。此次携手阿尔特，将进一步把首程的场景资源与产业生态，与阿尔特在整车研发、工程化能力与产业化经验深度结合。未来1-2年，合作将聚焦"机器人+汽车"的深度融合，率先在汽车研发、生产制造、智慧交通与出行服务等环节实现规模化应用示范，推动机器人从实验室走向产业化、规模化，加速形成具备示范效应的"机器人+汽车"应用矩阵。与此同时，合作也将放眼国际市场，推动中国方案走向全球，培育新质生产力，为股东创造长期价值。Posted by All Way Success Company Limited for Shoucheng Holdings www.shouchengholdings.com [HKSE:0697, FRA:SHVA, OTCPK:SHNHF] Copyright 2025 亚太商讯 via SeaPRwire.com.

HONG KONG, Aug 29, 2025 - (ACN Newswire via SeaPRwire.com) - China Everbright Limited ("CEL" or "the Company", stock code: 165.HK) announced its Interim results for the six months ended 30 June 2025 ("the reporting period").Highlights of the 2025 Interim Results- Strong Growth: Total income reached HK$2,068 million, representing a significant increase compared with the same period last year;- Turning Around from Loss to Profit: During the reporting period, the Company recorded a profit of HK$650 million, of which the net profit attributable to shareholders of the Company was HK$399 million, successfully turning around from a net loss;- Fundraising Increase: The total assets under management (AUM) of CEL's funds amounted to approximately HK$119.4 billion, with new fundraising amounting to approximately HK$2,741 million;- Successful Exits: The total exits from funds and principal investments amounted to HK$2.018 billionï¼›with a MOIC (multiple on invested capital) of approximately 2.78 times;- Cost Control and Efficiency Enhancement: Enhanced lean management led to a 10% year-on-year decrease in operating costs and a 38% year-on-year reduction in finance costs;- Adequate Liquidity: The Company had cash and cash equivalents of approximately HK$8.1 billion;- Steady Dividend: An interim dividend of HK$0.05 per share for 2025.In the first half of 2025, China's private equity industry entered a more stable stage of development. Leveraging its strengths as patient capital, CEL maintained strategic focus, seized market opportunities with precision, and promptly adjusted its fundraising, investment, management, and exit strategies. By consolidating its core businesses, gradually unlocking value potential, and significantly improving overall operational efficiency, the Company achieved a strong rebound in performance.During the reporting period, CEL realised total income of HK$2,068 million, representing a significant increase of HK$2,182 million from the same period last year. This was mainly due to a significant increase in investment income, which fully demonstrated the Company's sound investment vision and solid foundation in long-term investing. The Company recorded a profit of HK$650 million, of which the net profit attributable to shareholders of the Company amounted to HK$399 million, successfully turning around from a net loss attributable to shareholders of HK$1,282 million in the same period last year, representing a significant improvement in performance.Meanwhile, the Company continued to strengthen its refined management, sustaining healthy and steady business development. During the reporting period, operating costs represented a year-on-year decrease of 10%, with proactive leverage reduction measures implemented. The gearing ratio decreased by 2% compared with the end of 2024, while finance costs fell 38% year-on-year, demonstrating significant results in cost control and efficiency improvement. As at the end of June 2025, the Company had cash and cash equivalents of approximately HK$8.1 billion, representing sufficient liquidity.By concentrating its resources and business focus on high-potential products, the Company further reinforced its core business. During the reporting period, with new fundraising amounting to approximately HK$2,741 million, the total AUM of CEL’s funds amounted to approximately HK$119.4 billion, managing 72 fund products and covering primary market funds, secondary market funds, and fund of funds. During the reporting period, the Company invested in a total of 9 projects and exited, fully or partially, from 46 project.Following the practice of sharing the Company's operating results with shareholders, the Board declared interim dividend of HK$0.05 per share for 2025 (2024 interim dividend: HK$0.05 per share).Business Highlights in the First Half of 2025Firstly, CEL Harnessed the Strengths of Group-Based Operations to Enhance Fundraising SynergyIn the first half of 2025, the Company successfully launched the Huaian Hongze Guangqi Fund and the Xiamen Marine High-Tech Industrial Development Fund, with a total scale of RMB2.5 billion. The Huaian Fund targets growth-stage projects in the areas of new energy, new materials, and intelligent manufacturing, with its first round of capital contribution completed in the first half of the year. The Xiamen Marine Fund is dedicated to incubating and transforming scientific and technological innovations in the marine sector, driving the high-quality development of the marine economy. At the same time, several other funds have been approved and are progressing smoothly, following the established plan.Secondly, CEL Strengthened Core Businesses to Drive Robust Recovery in PerformanceDuring the reporting period, the Company total exits from funds and principal investments amounted to HK$2.018 billion. This include the full exit from Xpeng Motors, DAPU Telecom, and Taboola, alongside partial exit from iSoftStone, Dekon Food and Agriculture, 4Paradigm, and other projects. With a MOIC (multiple on invested capital) of approximately 2.78 times, these exits significantly boosted the DPI of multiple funds, generating substantial returns for LPs. Several listed projects, including Circle, Dekon Food and Agriculture, and NetEase Cloud Music, delivered strong market performance in the first half of the year, making notable contribution to the Company's investment returns. In the first half of the year, secondary market funds expertly capitalised on structural opportunities, achieving impressive investment performance. Notably, the Everbright Convertible Bond Opportunity Fund ranked second among similar funds in Barclays' performance rankings.Thirdly, CEL Anchored Strategy Around Scientific and Technological Innovation, With a Particular Focus on Key Industry SectorsGuided by deep industrial insight and a forward-looking strategic vision, the Company accelerated its investment activity in the first half of the year. It targeted emerging strategic industries such as artificial intelligence, chips and semiconductors, and biomedicine, with a total investment of approximately HK$264 million by funds. We have nurtured and supported a number of technology leaders, including Yangtze Memory and Wuhan Xinxin (both prominent domestic memory chip producers), HengYi Biotech (a company engaged in the research and development of innovative drug for tumors and autoimmune diseases), J-Sensor (astrategic supplier of domestic industrial automation modules and core sensors for new energy vehicles), and Tec-Do (a service provider in the field of big data and BI), among others. These investments reflect our commitment to strengthening China’s science and technology enterprises. Meanwhile, CEL supported excellent sub-funds such as Jinyi Capital and Eastern Bell Capital through its FoF platforms. These FoF investments allow us to fully leverage the advantages of resource amplification, risk diversification, and diversified returns.Fourthly, CEL Optimise Business Management to Unlock Growth MomentumIn the first half of the year, the Company continued to optimise its financing structure and took full advantage of the domestic interest rate cut cycle, issuing RMB3 billion in the first tranche of its 2025 medium-term notes at a coupon rate of 2.09% per annum — the lowest coupon rate in the Company's bond issuance history. During the reporting period, the Company's overall financing cost declined by 133 basis points year-on-year to 3.14%, while its finance costs reduced by 38% year-on-year. Operating costs also recorded year-on-year decrease of 10%, underscoring the solid progress made in reducing costs and increasing efficiency. The Company continued to optimise its risk management framework. CEL advanced the classification of risk assets, reinforced dynamic valuation management, and established a risk monitoring and early warning system, thereby improving the effectiveness of risk prevention and control across the full business cycle.Fifthly, CLE Enhanced Public Services and Upgraded Commercial Consumption.CEL leveraged its industrial strengths to enhance the quality of its products and services, catering to the growing demand for consumer services among citizens. In the commercial consumption arena, EBA successfully launched 18 "IMIX Park" shopping centres across nine cities nationwide,managing approximately 2.6 million square metres in total. These centres created approximately 37,700 jobs, attracted approximately 121 million customer visits, and hosted more than 4,500 tenant merchants in the first half of 2025. During the reporting period, Phase I of the "Zhongguancun ART PARK IMIX Parks", a flagship consumption infrastructure and urban renewal project in Beijing, opened smoothly, significantly upgrading the consumer experience and giving a strong boost to domestic demand.Sixthly, Key Portfolio Companies Maintain Stable Growth with Strong ResilienceThe core business of China Aircraft Leasing Group Holdings Limited (CALC) progressed steadily with remarkable improvements in operating quality and efficiency. The net profit attributable to shareholders recorded a year-on-year increase. As of June 30, 2025, CALC’s fleet reached 181 aircraft, leased to 41 airlines across 22 countries and regions. Everbright Senior Healthcare has been seizing the development opportunities in China's healthcare industry. As of 30 June 2025, Everbright Senior Healthcare has 237 institutions of various types in 49 cities across the country, it managed more than 30,000 beds, with occupancy rates increasing by 1.77%. Meanwhile, Terminus continued to deepen the integration of AI technology across multiple industries, driving intelligent transformation and implementing localised AI applications and digital-intelligent solutions, while receiving multiple authoritative certifications.Seventhly, CEL Strengthened ESG Framework to Promote Sustainable DevelopmentDuring the reporting period, CEL continued to promote the construction of its ESG system. the Company maintained an "A" rating in the MSCI ESG Rating and received the "BEST ESG (S)" award from the Hong Kong Investor Relations Association (HKIRA). The Company earnestly fulfilled its role as a corporate citizen by leveraging its own capabilities, organizing and participating in 46 cultural and social welfare activities in the first half of the year, serving over ten thousand people, and upholding high standards in discharging its social responsibilities.In the first half of 2025, under the strong leadership of the Everbright Group, the guidance of the Board of Directors, and the collective efforts of all employees, the Company achieved significant improvements in operational efficiency and quality, with new drivers of growth continuing to strengthen, resulting in hard-won achievements. As China's economy continues to improve and policy support intensifies, the Chinese private equity industry will embark on a new journey of high-quality development. CEL will seize market opportunities, capitalise on the momentum, and lay a solid foundation for a strong start to the 15th Five-Year Plan. In the second half of the year, CEL will continue to adhere to the overall principle of seeking progress while maintaining stability, continue to focus on revenue growth and cost control, optimise operational management, seize opportunities in key business areas such as fundraising, investment, management, and exit, leverage the cross-border platform and the synergistic advantages of the group, cultivate long-term patient capital, and advance the "five major financial initiatives", through scientific strategic planning, professional investment teams, and rigorous risk management, and continuously create value for shareholders.China Everbright Limited, https://www.everbright.com/en [SHSE:601818][HKEX:00165][OTCPK:CEVIF][OTCPK:CEVIY] Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Aug 29, 2025 - (ACN Newswire via SeaPRwire.com) - FWD Group Holdings Limited (“FWD Group” or “FWD”) today announced its interim results for the six months ended 30 June 2025.- New business sales were up 38 per cent to US$1.246 billion compared to 2024 on an annualised premium equivalent (APE) basis. New business contractual service margin (CSM) of US$794 million, with year-on-year growth of 34 per cent.- Operating profit after tax was up 9 per cent to US$251 million with continued positive contributions from each of the company’s four geographic reporting segments: Hong Kong SAR & Macau SAR; Thailand & Cambodia; Japan; and Emerging Markets.- Net profit of US$47 million is a record interim result under IFRS 17.- Further improved financial flexibility with an upgrade to FWD Group's ratings - with its notional insurer financial strength rating now A2 - as announced by Moody's in July 2025. Maintained a strong capital position with a 283 per cent solvency ratio* and net underlying free surplus generation that more than doubled to US$417 million. Dividends of over US$500 million were received from the geographic reporting segments. - Comprehensive tangible equity up 8 per cent to US$8.15 billion, and Group embedded value up 8 per cent to US$6.38 billion, reflecting the value created for shareholders during the first half of 2025. The company subsequently completed its IPO - which raised HK$3,611 million (approximately US$466 million) in gross proceeds – and began trading on 7 July 2025 under the stock code 1828 on the Hong Kong Stock Exchange.- Completed the build-out of a high-net-worth (HNW) hub in Asia operating out of three jurisdictions – Hong Kong SAR, Singapore and Bermuda – serving the global high-end insurance market with diversified asset allocation, wealth management and legacy planning. A new FWD Private lounge located in a prime commercial district in Hong Kong is now fully operational.Huynh Thanh Phong, Group Chief Executive Officer and Executive Director of FWD Group, said, “We’re delighted to report record interim results under IFRS 17 in our first earnings as a publicly listed company. The outstanding growth in new business CSM demonstrates our ability to execute our customer-led strategy successfully across Asia in a sustainable and profitable way.“We intend to use the net proceeds of our recent IPO to further enhance our capital position and financial flexibility, which may involve reducing debt, in support of further growth and reach with customers, digital capabilities and channels,” added Huynh Thanh Phong.In Hong Kong SAR & Macau SAR, outstanding growth was posted in new business sales and new business CSM, reflecting ongoing broad-based demand from both local and Mainland Chinese visitor customers and the full activation of the FWD Private HNW business. The company continues to focus on its multi-channel distribution strategy alongside product innovation – such as its indexed universal life offering developed following recent regulatory guidance, as well as new cross-border Greater Bay Area medical services for eligible customers.The Thailand & Cambodia reporting segment new business indicators were partly impacted by the exit from underwriting new business in the Thailand corporate care segment in 2024. The business remains well positioned in Thailand to meet demand for protection, medical and pension products from an aging population. Its exclusive bancassurance partnership with Siam Commercial Bank maintained its number one market position. Similarly, the company’s agents and advisors retained a number two position in the annual Million Dollar Round Table (MDRT) rankings released in July 2025. The MDRT is a global independent association recognised as a standard of excellence in the life insurance and financial services industries.In Japan, the business reported solid new business results from its individual protection focused portfolio. The introduction of its first savings offering in July – a Japanese yen single premium annuity product – marked the company’s entry into the savings and retirement needs market. The Emerging Markets segment reported strong new business sales growth, despite industry headwinds and economic uncertainty in several markets. In Indonesia, BRI Life – a joint venture where FWD Group holds a strategic 44 per cent investment and collaborates with Bank BRI – was number one in bancassurance by new business sales. In the Philippines and Vietnam, the company’s agents and advisors ranked number two in the latest annual MDRT rankings. Six months ended/as at 31 Dec or 30 Jun^ US$ millions, except for percentages2025 2024Growth(year on year CER basis) Profitability Operating profit after tax2512239% Net profit/(loss)473nm CSM balance5,9965,17411% Growth New business sales (APE)1,24687638% New business CSM79457334% Value of new business50640421% Customer indicators Purchase customer emotion – good or great92%92%n/a Claims customer advocacy – net promoter score6364n/a Risk & Capital Net underlying free surplus generation417193115% Group local capital summation method coverratio*283% 260%n/a Value Group embedded value6,3805,5698% Comprehensive tangible equity8,1507,1628% Return on tangible equity17%15%n/a About FWD GroupFWD Group (1828.HK) is a pan-Asian life and health insurance business that serves approximately 34 million customers across 10 markets, including BRI Life in Indonesia. FWD’s customer-led and tech-enabled approach aims to deliver innovative propositions, easy-to-understand products and a simpler insurance experience. Established in 2013, the company operates in some of the fastest-growing insurance markets in the world with a vision of changing the way people feel about insurance. FWD Group is listed on the main board of the Hong Kong Stock Exchange under the stock code 1828. For more information, please visit www.fwd.comFor media inquiries, please contact: groupcommunications@fwd.comSource: FWD Group Holdings Limited^ The results are for the six months ended 30 June 2025 and are compared to the same period in 2024. CSM balance, Group LCSM cover ratio, group embedded value, comprehensive tangible equity and return on equity 2024 values are December 2024 balances/ratios and growth rates are shown accordingly. Growth rates are represented on a constant exchange rate (CER) basis. Except for operating profit/(loss) after tax (non-IFRS measure), net profit/(loss), CSM, and comprehensive tangible equity, all other numbers are unaudited. Operating profit after tax and net profit after tax represent the amounts attributable to equity holders of the company and are presented net of non-controlling interests. New business sales are calculated on an annualised premium equivalent (APE) basis, based on 100 percent annualised first year premiums and 10 percent single premiums. Return on tangible equity is calculated as operating profit after tax, divided by the average of the balances of tangible equity as of the beginning and end of such period. Tangible equity is calculated as adjusted total equity attributable to shareholders of the company, minus the intangible assets net of non-controlling interests.*Prescribed capital requirement (PCR) basis Copyright 2025 ACN Newswire via SeaPRwire.com.

SAN DIEGO, Aug 28, 2025 - (ACN Newswire via SeaPRwire.com) - The YFQ-42A Collaborative Combat Aircraft, designed and developed by General Atomics Aeronautical Systems, Inc. (GA-ASI), is now conducting flight testing in coordination with the U.S. Air Force. This historic achievement continues the company's rapid creation of new, jet-powered uncrewed platforms chartered by the U.S. Air Force (USAF) to achieve air dominance while being designed for rapid production, in large quantities, at an affordable price."What a great moment for the U.S. Air Force and for GA-ASI," said GA-ASI President David R. Alexander. "It's been our collaboration that enabled us to build and fly the YFQ-42A in just over a year. It's an incredible achievement and I salute the Air Force for its vision and I salute our development team for delivering yet another historic first for our company."The YFQ-42A is GA-ASI's newest uncrewed jet, focused on air-to-air semi-autonomous operation and based on the genus-species concept pioneered on the XQ-67A Off-Board Sensing Station (OBSS). Using state-of-the-art, model-based digital engineering, GA-ASI was able to accelerate its schedule while optimizing air dominance capabilities. YFQ-42's autonomy core has been trained across more than five years of flight testing using GA-ASI's jet-powered MQ-20 Avenger®, an aircraft no other company has. The integrated capabilities of a stealthy, air-to-air-focused uncrewed jet, combined with a learned AI autonomy core, provide warfighters with a definitive advantage in the future fight.The GA-ASI program has focused on creating a high-rate production environment that enables USAF to reach its goal of producing more than 1,000 CCAs on an accelerated timeline. Ground testing for YFQ-42A began in May.USAF selected GA-ASI in April 2024 to build and fly a fully production-representative Collaborative Combat Aircraft (CCA). In March, USAF designated the aircraft the YFQ-42A, with the "Y" indicating a production-representative aircraft ("Y" will be dropped upon entering production), "F" signifying a fighter aircraft, and "Q" denoting an uncrewed aircraft.GA-ASI has developed more than two dozen different types of uncrewed aircraft and delivered more than 1,200 units to customers, building more than 100 aircraft per year at its 5 million-square-foot manufacturing facility in Poway, Calif. GA-ASI aircraft have amassed nearly 9 million total flight hours; more than 50 GA-ASI aircraft are aloft around the world every minute of every day.About GA-ASIGeneral Atomics Aeronautical Systems, Inc., is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging nearly 9 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc. registered in the United States and/or other countries.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com.